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Post-transcriptional regulation is emerging as an essential mechanism to diversify eukaryotic gene 
expression. Neurons take great advantage of several regulatory mechanisms, including RNA stability, 
poly-A tailing, gene silencing, and translational activation, to diversify their functional properties. 
RNA-binding proteins (RBPs) may thus have evolved neuron-specific regulatory mechanisms to 
support complex and prompt changes in neuronal gene expression and the relevant physiologies such 
as circadian clocks and neurodegeneration. The translational regulator TWENTY-FOUR (TYF) 
associates with the Drosophila homolog of ATAXIN-2 (ATX2) to activate the translation of the rate-
limiting circadian clock gene period (per), thereby defining a post-transcriptional co-activator function 
of ATX2 in Drosophila circadian clocks. ATX2 has also been increasingly implicated in 
neurodegenerative diseases. However, it is poorly understood how ATX2-associating factors assemble 
into a specific protein complex and how they contribute to the physiological function of the ATX2 
complex in vivo.  
To address these questions, we first performed an in vivo genetic screen for the clock function 
of ATX2-associating proteins. This approach identified LSM12 (like-Sm protein 12) and ME31B, as 
two key components of the ATX2 complex sustaining circadian periodicity and rhythm amplitude, 
respectively. We established a Drosophila model of Lsm12 deletion by imprecise excision of a P 
element insertion. Our Lsm12-deletion flies exhibited abnormal circadian rhythms with long-period, as 
similarly seen in tyf mutants and Atx2-deficient flies that were caused by dampened PER oscillation in 
circadian pacemaker neurons. In contrast, ME31B-depleted flies exhibited poor rhythmic behaviors via 
a PER-independent ATX2 pathway. These results suggest that LSM12 and ME31B have distinct roles 
in post-transcriptional regulation by the ATX2 protein complex. 
A series of biochemical analyses revealed that LSM12 acts as a molecular adaptor of the 
ATX2-associating protein complex to recruit TYF. The ATX2-LSM12-TYF complex is associated with 
5’ cap-binding proteins in an ATX2-dependent manner, thereby supporting TYF-dependent 
translational activation. On the other hand, ME31B/DDX6 facilitated the selective association of ATX2 
with a scaffold protein NOT1 of the CCR4-NOT deadenylase complex to support NOT1-mediated gene 
silencing activity. We thus propose that the ATX2 protein complex switches between activator and 
repressor modes of post-transcriptional regulation via its associating factors LSM12 and ME31B. It 
defines PER-dependent and -independent clock functions of ATX2 that contribute to 24-hour 
periodicity and high-amplitude rhythms, respectively, in Drosophila circadian behaviors. 
Since the biochemical association of LSM12 with ATX2 is well conserved between 
Drosophila and humans, we next sought to explore whether LSM12 would play similar roles in other 
ATX2-relevant physiology such as neurodegeneration. We performed an in vivo genetic screen with 
5 
transgenic Drosophila models of neurodegenerative diseases, including C9ORF72-associated 
amyotrophic lateral sclerosis and frontotemporal dementia (C9-ALS/FTD), spinocerebellar ataxia 3 
(SCA3), and Alzheimer’s disease. Interestingly, we observed C9-ALS/FTD-induced neurodegeneration 
was exacerbated in Drosophila mutants of Lsm12, indicating its neuroprotective function. 
Nucleocytoplasmic transport (NCT) defects are increasingly implicated in the pathogenesis of 
C9-ALS/FTD. We thus asked whether the disruption of NCT would explain LSM12-dependent 
molecular pathogenesis of C9-ALS/FTD. We identified a neuroprotective pathway of LSM12 and 
EPAC1 (exchange protein directly activated by cyclic AMP 1) that sustained the nucleocytoplasmic 
RAN GTPase (RAN) gradient, a key NCT regulator, and thereby suppressed NCT dysfunction by the 
C9ORF72-derived poly(glycine-arginine) protein. LSM12 depletion in human neuroblastoma SH-
SY5Y cells aggravated poly(GR)-induced impairment of NCT and nuclear integrity while promoting 
the nuclear accumulation of poly(GR) granules. Overexpression of ALS-associated LSM12V135I mutant 
comparably increased poly(GR) toxicity, indicating dominant-negative effects. Transcriptome and 
reporter analyses revealed that LSM12 post-transcriptionally up-regulated EPAC1 expression, whereas 
EPAC1 overexpression rescued the RAN gradient and NCT defects in LSM12-deleted cells. Poly(GR)-
induced neurodegeneration was consistently exacerbated in Drosophila Epac mutants. 
Finally, we employed induced pluripotent stem cell (iPSC)-derived neurons from C9-ALS 
patients (C9-ALS iPSNs) to validate the physiological relevance of our findings. Lentiviral 
overexpression of LSM12 or EPAC1 indeed rescued NCT-relevant pathologies in C9-ALS iPSNs. 
These findings support our conclusion that LSM12 and EPAC1 constitute a neuroprotective pathway 
for sustaining the RAN gradient and NCT in the pathophysiology of C9ORF72-associated ALS/FTD. 
A series of biochemical experiments revealed that EPAC1 was essential for associating the RAN-
importin β1 complex with the cytoplasmic nuclear pore complex, thereby dissipating the 
nucleocytoplasmic RAN gradient critical for NCT. These findings define a conserved role of the 
LSM12-EPAC pathway as an important suppressor of the NCT-related pathologies in C9-ALS/FTD. 
Taken together, my thesis research has elucidated the molecular principles underlying LSM12-
dependent post-transcriptional gene regulation and provided insights into the molecular pathogenesis 
of circadian disruption and ALS. 
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I-1. Circadian clock 
Circadian clocks are an intrinsic, autonomous molecular oscillators of physiological, behavioral, and 
biochemical activities to adapt to environmental changes [1, 2]. Most living organisms, including 
bacteria, fungi, plants, and animals, have been observed to utilize internal timing systems to resonate 
with the cycle of earth’s rotation [3]. Given that evolutionarily unrelated organisms share the principle 
of circadian transcriptional network, the circadian clock system seems to be a product of convergent 
evolution [4]. The circadian clock is able to keep running almost living organism’s behavior under 
constant environmental conditions with 24-hour periodicity [5]. These clock cycles distribute timing 
signals across the body, including the brain and other tissues to temporally control the activity and 
function of organs [6, 7]. However, it does not mean that they work altogether. For example, neural 
circuits important for cognitive behavior and attention are activated in daytime, whereas pathways 
essential for sleep-dependent memory consolidation and synaptic plasticity are upregulated in nighttime 
for diurnal species [8-10]. Nocturnal species such as mice are oppositely phase-shifted to light-darkness 
cycle [11].  
The cellular clock stage relative to external time is determined by environmental times termed 
zeitgebers. Zeitgebers include light, temperature, mechanosensory stimulus, and control the intrinsic 
circadian clock by regulating synchrony between the internal circadian rhythms and external light-
darkness cycles to optimize the fundamental behaviors and cellular processes [12-15]. The principal 
circadian pacemaker is a network of neurons and glia in the brain, which are necessary for synchronizing 
external zeitgebers and transmitting temporal signals to peripheral clocks throughout the body [7]. 
Furthermore, the coordination of central and peripheral clocks required for circadian rhythmicity is 
mediated by nervous system, hormones and body temperature [16-18]. Otherwise, circadian disruption-
mediated of physiological dysfunction has severe consequence on overall health. Recently, disruption 
of circadian clock has been proposed as significant contributors to pathogenesis of many diseases, 














Figure I-1. Circadian rhythms are adaptations of organismal physiology to resonate with the 24-
hour day. 
Circadian rhythms are central regulatory system for all physiological activities, including cell cycle, 
immune response, hormone secretion, sleep and wake with cell-autonomous manner [25]. (Adapted 












I-2. The molecular basis of the circadian clock 
The central circadian pacemaker in mammals is located in the suprachiasmatic nucleus (SCN) of the 
hypothalamus, and heterogeneous cluster of approximately 10,000 SCN neurons have cell-autonomous 
circadian program [26, 27]. It was validated that SCN neurons exhibit electrical and molecular neural 
signaling coupled with circadian rhythms of membrane potential and spontaneous firing rate [28, 29]. 
The response of SCN neurons to incoming light signals involves the activation of CAMKII, NMDA 
receptors, and transcriptional and post-transcriptional gene expression [30-32].  
The specific machinery for maintaining circadian clocks differ from organism to organism, 
but they share a set of core clock genes, implicating evolutionarily conserved core clock mechanism 
across species. Drosophila has been studied as a model system of circadian rhythm due to its availability 
of powerful genetic tools and robust circadian clocks in visual photoreceptors, olfactory neurons, 
eclosion, and learning and memory circuits [33-36]. Anticipatory activity under light/dark (LD) 
entrainment condition is a hallmark of Drosophila circadian clock [37]. Restricted set of approximately 
150 pacemaker neurons in the fly brain, which serves a function similar to SCN in mammals, controls 
circadian clock. These neurons are organized into several groups. Four pairs of large and five pairs of 
small ventral lateral neurons (l-LNv and s-LNv, respectively) express a neuropeptide pigment-
dispersing factor (PDF), which provides a signal to synchronize core clock neurons, except for one pair 
of s-LNv which is PDF-negative. The PDF-positive l-LNv is important for light response by receiving 
light input from the eye photoreceptor neurons, whereas the PDF-positive s-LNv are involved in 
morning anticipation. Some of dorsal neurons (DN), dorsal lateral neurons (LNd), and PDF-negative s-
LNv are involved in evening anticipation. In addition, it has been suggested that lateral posterior 
neurons (LPN) are involved in temperature-dependent circadian conditions [37-39].  
As central clock sends out the timing information to peripheral clock, they both share similar 
and conserved molecular mechanism of transcriptional translational feedback loop (TTFL) [7, 25, 40]. 
The core components of this loop are the transcription factor CLOCK (CLK) and CYCLE (CYC). They 
form a heterodimer (CLK/CYC) and bind to E-box regulatory elements to activate transcription of 
period (per), timeless (tim), and other downstream genes, including vrille (vri), PAR domain protein 1 
(Pdp1) and clockwork orange (cwo). Newly translated PER and TIM proteins form a heterodimer 
(PER/TIM) and translocate into the nucleus to repress CLK/CYC-driven transcription, generating anti-
phase mRNA oscillations. In exposure to light at daytime, TIM is degraded by intracellular 
photoreceptor, cryptochrome (CRY), triggering phosphorylation of PER by double-time (DBT) and 
subsequent proteasomal degradation. Thus, at the transcriptional, post-transcriptional, and post-
translational regulation of oscillating heterodimer complexes CLK/CYC and PER/TIM and 





Figure I-2. Core components of the Drosophila and mammalian circadian clock. 
Circadian transcription–translation feedback loops (TTFLs) are conserved across species and generate 
daily rhythmic expression of clock and clock-controlled genes. CLK/CYC in Drosophila or 
BMAL1/CLOCK in mammals bind to E-box sequences to activate transcription of clock-relevant genes 











I-3. Post-transcriptional regulation by RNA-binding proteins in circadian 
clock 
Post-transcriptional regulation diversifies eukaryotic gene expression via a wide range of regulatory 
mechanisms. Tissue-specific transcriptomic analyses have indicated that neuronal mRNAs are potent 
substrates for the post-transcriptional processing such as alternative splicing and polyadenylation [42, 
43]. RNA-binding proteins (RBPs) thus have evolved neuron-specific regulatory mechanisms to 
support complex and prompt changes in neuronal gene expression. Consistent with this, post-
transcriptional regulation has been suggested as an important clock mechanism for sustaining circadian 
gene expression in pacemaker neurons [44]. In Drosophila, the translational regulator TWENTY-
FOUR (TYF) associates with poly A binding protein (PABP) to activate a translation of PER protein 
[45]. It has been further demonstrated that ATAXIN-2 (ATX2 in Drosophila /ATXN2 in human) 
associates and coordinates a TYF-PABP circadian translation complex to activate PER translation [46]. 
ATX2 depletion and tyf mutant flies exhibit arrhythmic circadian behavior with longer period as well 
as disrupted PER oscillation in central pacemaker neurons. In contrast, PER induction significantly 
rescues Atx2 and tyf phenotypes, indicating that PER is translational target of ATX2 and TYF in the 
core clock. 
 Fragile X mental retardation protein (FMRP) is a well-known RBP that associates with 
translating ribosomes and mediates local translation of synaptic proteins in response to neuronal activity 
[47]. Mutations in FMRP result in Fragile X syndrome (FraX), the most commonly inherited form of 
autism spectrum disorders [48]. Consistent with altered sleep and rhythms in patients with FraX, 
mutations in Drosophila and mouse homologs of FMRP disrupt sleep and circadian activity [49, 50]. 
Ribosomal stalling and/or miRNA-mediated gene silencing has been suggested as post-transcriptional 
regulatory mechanisms of FMRP [51, 52], yet specific target genes remain unknown. These data 
suggest that post-transcriptional regulation acts as an key mechanism to organize temporal coordination 














Figure I-3. Post-transcriptional control of circadian clock. 
(A) Cytoplasmic translational activation and repression by RBPs and miRNAs. RISC indicates RNA-
induced silencing complex. (B) ATX2-TYF complex activates Drosophila PER translation. (C) 
CLOCK translation is driven by cold-inducible RNA binding protein (CIRP) in mammalian cells [44]. 

















I-4. ATAXIN-2-relevant neurodegenerative diseases 
ATXN2 is highly conserved in eukaryotes, including fungi, plants, and animals. ATXN2 has three 
domains important for its post-transcriptional activity [53]. N-terminal like-Sm (Lsm) domain, Lsm-
associated domain (LsmAD), and PABP-interacting motif 2 (PAM2) domain has been implicated in 
association with RBPs and RNA molecules to regulate poly-A tailing, translation, mRNA decay, and 
miRNA-dependent gene silencing [54-57]. Given that ATXN2 proteins are highly expressed in 
cerebellar Purkinje cells among other brain regions [58], it is thus plausible that ATXN2 and its 
associated protein complex act as an transacting module for post-transcriptional control of neural 
functions and plasticity.  
ATXN2 has also been correlated with other neurodegenerative diseases, such as 
spinocerebellar ataxia 2 (SCA2), amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s 
disease), frontotemporal dementia (FTD), and Parkinson’s disease [59-61]. SCA2 is an autosomal-
dominant neurodegenerative disease that is caused by mutational expansion of the polyglutamine 
(polyQ) tract in the gene product of human ATXN2 [62, 63]. More than 34 repeats of CAG triplet 
repeats are found in the ATXN2 loci of SCA2 patients with severe neuronal loss in Purkinje cells. In 
addition, ATXN2 proteins accumulate with age, and localize to cytoplasmic puncta that is observed to 
be molecular basis for their pathogenesis. [58]. It has been observed that ATXN2 depletion mitigates 
other neurodegenerative disease models of TAR-DNA binding protein 43 (TDP-43) and ATAXIN-1 
(ATXN1) [59, 64, 65]. In addition, the neuronal pathologies that involve ATXN2-postive aggregates 
differ noticeably between neuronal populations. The accumulation of ATXN2 proteins in the spinal 
cord neurons might be detrimental for ALS pathogenesis, whereas this accumulation is not observed in 
the affected cerebellum of SCA2 patients [59, 66]. These observations suggest that ATXN2-dependent 
neurodegeneration may involve specific mechanisms beyond the generic neurotoxicity of aberrant 
protein aggregations. However, it still remains controversial whether the loss of ATXN2 function or 
gain of function causes neuronal toxicity. Given the diverse post-transcriptional activity of ATXN2 in 
neural function such as translational activation and miRNA/deadenylase-dependent gene silencing [46, 
55, 67], it might be reasonable to hypothesize that ATXN2 would differentially modulate 









I-5. ALS and FTD 
ALS is a fatal neurodegenerative disease affecting upper and lower motor neurons located in brainstem, 
spinal cord and frontal cortex. Besides loss of motor neurons, ALS is characterized by progressive loss 
of motor neurons, paralysis, and respiratory failure that manifests behavioral disorders and cognitive 
impairment [68]. ALS shares its pathological hallmarks with FTD, a clinically distinct 
neurodegenerative disorder that accompanies behavioral changes and language difficulties [69, 70]. 
FTD encompasses a broad spectrum of clinical presentations with phenotypes including deficits in 
cognitive functions, language and behavioral changes. A close relationship between ALS and FTD has 
been obvious based on pathological features and symptoms of the two neurodegenerative diseases [69]. 
The association between ALS and FTD has been investigated that up to 50% of ALS patients 
show FTD-associated cognitive impairment. Conversely, up to 30% of FTD patients show ALS-
associated motor neuron dysfunction [71]. Cellular deposition of protein inclusions is a pathologic 
hallmark of both ALS and FTD. For ALS, almost 98% patients exhibit cytoplasmic mislocalization and 
aggregation of TDP-43 [72]. For FTD, 40% patients exhibit TDP-43 mislocalization-associated 
neuropathology. Other frequently observed genetic factors include the aggregation of fused in sarcoma 
(FUS), superoxide dismutase 1 (SOD1), heterogeneous nuclear ribonucleoproteins (HNRNPs), and 
ATXN2 [59, 73-75]. More recently, remarkable progress was made with the discovery that a mutation 
in chromosome 9 open reading frame 72 (C9ORF72) gene is strongly associated with both ALS and 

















Figure I-4. Clinical, genetic, and pathological overlap of ALS and FTD. 
ALS and FTD are recognized as representatives of a continuum of broad neurodegenerative diseases 
with each presenting in a spectrum of overlapping pathological symptoms. They share pathological 










I-6. C9ORF72-associated ALS/FTD 
In 2011, a hexanucleotide GGGGCC repeat expansion in C9ORF72 intronic region was identified as a 
significant genetic cause of both ALS and FTD [76, 77]. Further study have found that this repeat 
expansion is the most common genetic cause of familial ALS (41%) and FTD (25%) [79]. In addition, 
this mutation is observed in some sporadic cases of ALS (8%) and FTD (5%). C9ORF72-associated 
pathogenesis have also been observed as rare causes of neurodegenerative diseases, including 
Parkinson’s disease, Alzheimer’s disease, ataxia, Huntington disease-like syndrome, and Creutzfeldt-
Jakob disease [80-82]. Larger expansions ranging from hundreds to thousands of hexanucleotide repeats 
in the C9ORF72 gene are commonly observed in patients with C9-ALS/FTD, while 95% of healthy 
individuals have less than 11 hexanucleotide repeats.  
Several pathogenic mechanisms have been suggested by genetic studies in C9-ALS/FTD models. 
One of the hypotheses is that haploinsufficiency of C9ORF72 protein leads to the disease process. 
Impaired endosomal and lysosomal trafficking were reported in C9ORF72 knockout mice, and reduced 
endocytic activity was observed in C9ORF72-depleted cell lines [83-85]. These data suggest that 
C9ORF72 protein have a role in cellular vesicle trafficking events and that loss of C9ORF72-associated 
endolysosomal and autophagic defects contributes to neurodegeneration in C9-ALS/FTD. In 
C9ORF72-associated ALS/FTD, the PAF1 (RNA polymerase II-associated factor 1) complex and 
transcription elongation factor SUPT4H1 (suppressor of Ty 4 homolog 1) promote bi-directional 
transcription from C9ORF72-associated repeats [86, 87]. These RNA molecules containing repetitive 
sequences form pathogenic secondary structures that sequester RNA-binding proteins in a 
conformation-specific manner and interfere with their relevant function [88, 89]. Accordingly, it has 
been suggested that the gain of RNA toxicity is responsible for the pathogenesis of C9ORF72-
associated ALS/FTD [90, 91]. Furthermore, C9ORF72 repeats encoded in both sense and antisense 
RNAs are translated into five different dipeptide repeat (DPR) proteins via repeat-associated non-AUG 
translation of all possible reading-frames [92, 93]. While all DPR proteins are detected in C9ORF72-
related ALS/FTD patients [92, 94], it has been demonstrated that a subset of DPR proteins (i.e., 
poly(GR), poly(PR), and poly(GA) proteins) form intracellular inclusions and impair specific aspects 
of cellular physiology [69, 95, 96]. Thus, the cytotoxic effects of these non-canonical translation 
products are emerging as a key mechanism that contributes to neurodegeneration [97]. Poly(GR) and 
poly(PR) proteins localize to nucleoli, translocate the nucleolar phosphoprotein B23 (also known as 
NPM1) into the nucleoplasm, and impair both pre-mRNA splicing and ribosomal RNA processing [98-
101]. DPR-induced nucleolar stress is thus emerging as one of the key pathogenic mechanisms 





Figure I-5. C9ORF72-assoicated ALS/FTD neuropathology. 
DPRs are generated by sense and antisense strand of GGGGCC repeat expansion RNA. Sense and 
antisense RNA foci and aggregates of DPRs are a common feature of C9ORF72-associated ALS/FTD 

















I-7. Nucleocytoplasmic transport  
Nucleocytoplasmic transport (NCT) of proteins and RNA particles is crucial for maintaining 
nucleocytoplasmic homeostasis of eukaryotic cells [103]. Small molecules passively diffuse through 
the way of nuclear pore complex (NPC), which consists of ~30 nucleoporins (NUPs), whereas transport 
of large molecules is facilitated by transport receptors. Imported cargo from cytoplasm is unloaded by 
binding to GTP-bound form of a RAN GTPase (RAN) in the nucleus. RAN is an evolutionarily 
conserved, small GTPase that shuttles between the nucleus and cytoplasm in two alternating forms: 
GTP-bound and GDP-bound [104-106]. The opposing activities of RANGAP1 (RAN GTPase-
activating protein 1) at the cytoplasmic side of the nuclear pore complex and of chromatin-associating 
RANGEF (RAN guanine nucleotide exchange factor, also known as RCC1), establish a steep 
nucleocytoplasmic gradient of RAN-GTP [107, 108]. The RAN-GTP/GDP state subsequently switches 
its binding affinity between nuclear transport factors, thereby defining the directional NCT of a given 
cargo protein via the NPC [109].  
Physiological aging has been highly associated with dysfunction of NCT and invagination of 
the nuclear membrane [110]. Age-dependent transcriptome changes of several nuclear transport factors 
lead to disruption of NCT [111]. Neurons are particularly sensitive to the damage of NPC structure and 
NCT function as they are deteriorated by long-lived proteins in post-mitotic cells [112]. Perturbation of 
NCT has also recently emerged as a mechanism contributing to neurodegenerative diseases, such as 
ALS/FTD, Huntington’s disease, and Alzheimer’s disease [113-117]. Genetic studies in yeast, 
Drosophila, and in vitro cell culture models of C9ORF72-associated ALS/FTD have further identified 
several cellular factors involved in NCT as genetic modifiers of DPR cytotoxicity [95, 118-122]. TDP-
43, a genetic factor of C9-ALS/FTD, harbor a nuclear localization signal (NLS) and a putative nuclear 
export signal (NES) and is predominantly located in nucleus. TDP-43 is known to be imported into the 
nucleus by the RAN gradient-dependent activity of importin β1 [123, 124]. Disruption of transport 
activity by depletion of importin β1 leads to cytoplasmic mislocalization of TDP-43 and accumulation 
of transport factors and NUPs into TDP-43 aggregates. It results in disruption of nuclear membrane 
integrity and NPC structure [125]. As NCT-related factors (e.g., RAN, importins, exportin-1, POM121, 
NUPs, and THOC2) have been observed to localize to DPR-induced stress granules (SGs) [126], it is 
likely that DPRs disrupt NCT through sequestration of NCT-related factors into SGs, resulting in the 
failure of messenger ribonucleoproteins (mRNPs) homeostasis. More direct effects of poly(GR) and 









Figure I-6. Schematic overview of RAN-dependent nucleocytoplasmic transport. 
RAN-GTP/GDP ratio drives import and export of RNAs and proteins through the NPC. RANBP2-
RANGAP1 recruits the RAN-GTP-importin β1-cargo complex to the cytoplasmic side of the nuclear 
pore complex, facilitating its recycling across the nuclear membrane [113]. (Adapted from Kim, H. J., 




Figure I-7. Disruption of NCT in neurodegenerative diseases. 
The pathological feature in most cases of ALS and FTD is the cytoplasmic mislocalization of TDP-43 
in patient neurons, leading to accumulation of cytotoxic aggregates, dysfunction of NCT, and 










I-8. Stress granule 
SGs are cytoplasmic assemblies of mRNPs that are formed under diverse cellular stresses and are 
thought to support cellular homeostasis of RNA and RNA-binding proteins [128]. SGs are 
evolutionarily conserved in eukaryotes, composed of diverse proteins some of which are essential for 
SG assembly and others are recruited by indirect manner. The buffering capacity of SG assembly in 
response to cellular stresses has major advantages for cellular physiology; it protects cellular RNAs 
from degradation, minimizes energy expenditure, inhibits RNA translation, and protects cytotoxicity 
[129]. Early studies suggested that arsenite-induced oxidative stress or heat-shock stress induce α-
subunit of eukaryotic translation initiation factor 2 (EIF2α) phosphorylation-dependent formation of 
SGs in mammalian cells, preventing GDP/GTP exchange for EIF2-GFP-tRNAMet [130]. It results in 
inhibition of the 43S pre-initiation complex assembly, polysome assembly, and cap-dependent 
translation. On the other hands, recent evidence found EIF2α phosphorylation is not mandatory for SG 
assembly in some cases of stress [131, 132]. Changes in the composition of the cap-binding complex 
EIF4F, composed of EIF4A, EIF4E, and EIF4G, control translation initiation and thereby induce SG 
assembly by EIF2α phosphorylation-independent manner.  
SGs are thought to form through a process of liquid-liquid phase separation (LLPS), the 
biochemical formation of two immiscible fluids from a homogeneous mixture of RNA molecules and 
RBPs that intrinsically disordered regions (IDRs). It has been shown that SGs are often enriched in 
proteins with IDRs (e.g., TDP-43, ATXN2, FUS, HNRNPs, and TIA1) [73]. Many IDRs do not adopt 
a unique state of structure but rather they have many interconvertible conformations, facilitating self-
interaction through short stretches of amino acids or interaction between IDRs and other domains 
involving transient order. IDRs has advantages for regulating promiscuous assembly of large complexes, 
increasing interaction between multiple subcomplexes within larger RNPs. Moreover, IDRs have 
shown to be targets for post-translational modifications, implicating their functional modulation [133]. 
It has been observed that many ATPases, including RNA helicases, chaperones are SG 
components and pharmacological depletion of ATP significantly inhibits SG dynamics [134, 135]. It 
potentially supports a general model of SG assemblies as active liquids where ATP-driven energy is 
required to keep them in a dynamic state, releasing mRNAs to the cytoplasm to resume translation. 
Notably, it has been shown that several ALS/FTD-related genetic factors (e.g., TDP-43, ATXN2, FUS, 
HNRNPs, and TIA1) are SG components and are associated with nucleocytoplasmic aggregates, 
implicating the impairment of homeostatic response to stress as a pathogenic mechanism. Interestingly, 
C9ORF72-derived arginine-containing DPR proteins, poly(GR) and poly(PR), associate with RBPs that 






























S2 cells were cultured in Shields and Sang M3 insect medium (Sigma-Aldrich) supplemented with 10% 
fetal bovine serum and 1% penicillin-streptomycin (Thermo Fisher Scientific) at 25°C. For maintenance, 
cell cultures with 100% confluency were split at 1:4 dilution with fresh media. For transient transfection 
or incubation with double-stranded RNAs, S2 cells were diluted from the confluent culture at 1:2.6 on 
the same day of the experiments. Transient transfections were performed using Effectene Transfection 
Reagent according to the manufacturer’s instructions (QIAGEN). Human neuroblastoma SH-SY5Y and 
human embryonic kidney 293T cells were cultured in Dulbecco’s Modified Eagle Medium (HyClone) 
supplemented with 10% fetal bovine serum and 1% antibiotics and maintained at 37°C in a humidified 
incubator with 95% air and 5% CO2. Plasmid DNA and siRNA were transiently transfected using 
polyethylenimine [139] and Lipofectamine RNAiMAX transfection reagent (Thermo Fisher Scientific), 
respectively, according to the manufacturer’s instructions. C9-ALS iPSC lines (CS28iALS, CS29iALS, 
and CS52iALS) and control iPSC lines (CS0YX7iCTR, CS29iALS-ISO, and CS4NWCiCTR) were 
obtained from the Cedars-Sinai iPSC Core. iPSCs were cultured on Matrigel-coated plates (Corning) in 
mTeSR1 medium (STEMCELL Technologies) in a humidified incubator with 95% air and 5% CO2 
with daily media changes. Motor neuron differentiation from iPSCs was induced, as described 
previously [140]. Where indicated, neural progenitor cells (NPCs) were transduced with concentrated 
aliquots of recombinant lentiviruses in the presence of 5 µg/ml polybrene for 6 hours to overexpress 




Flies were raised on standard cornmeal-yeast-agar medium (5.4% cornmeal, 1.3% yeast, 0.7% soy flour, 
0.4% agar, 4.2% starch syrup, 0.4% propionic acid, and 0.8% methyl 4-hydroxybenzoate) at 25°C. We 
tested ~one week old male flies in all the behavioral analyses. Virgin female flies trans-heterozygous 
for the genomic deletion alleles in Lsm12 locus were tested for the genetic complementation in free-
running circadian behaviors. For immunoprecipitation, immunoblotting and quantitative transcript 
analyses, both male and female flies of the same genotype were sampled in groups. CG15735EY01098 (a 
P element insertion upstream of the transcription start site of Lsm12), Df(1)ED7153 (a chromosomal 
deficiency line covering Lsm12 locus), and Atx2206490 (a hypomorphic P element insertion in the 5’ 
untranslated region, upstream of the translation start codon of Atx2)[141] were obtained from 
Bloomington Drosophila stock center. P element excision lines from the EY01098 allele were 
established by a standard genetic scheme and verified by the PCR amplification of isolated genomic 
DNA with appropriate sets of primers and DNA sequencing. RNAi stocks including Atx2 RNAi 
32 
(v108843), Lsm12 RNAi (v101762, T34666), me31B RNAi (T28566, T38923, 4916R-2), Not1 RNAi 
(T28681), and Epac RNAi (v43444, v110077) were obtained from Bloomington Drosophila stock 
center, NIG-Fly stock center, and Vienna Drosophila RNAi center. UAS-LSM12 transgenic lines were 
generated by germ-line transformation with the transgenic construct harboring LSM12 cDNA under the 
control of UAS (BestGene Inc.). Pdf-Gal4, tim-Gal4, cry-Gal4, Mz520-Gal4, Elav-Gal4, Elav-
GeneSwitch-Gal4, UAS-PER16, UAS-ATX2-3F, UAS-TYF-3F, UAS-TYFΔC5-3F, UAS-TYFΔC5-
V5, and p{13.2per-HAHis} transgenic lines were described previously [45, 142, 143]. Drosophila 
UAS-poly-GR.PO-36 (BL58692), Epac deletion mutant (EpacD1/EpacD3, BL78799) lines were obtained 
from the Bloomington Drosophila Stock Center and Vienna Drosophila Resource Center. 
 
Behavioral analyses 
Individual flies were placed into glass vials containing 5% sucrose and 2% agar, entrained by four light: 
dark (LD) cycles of 12 hr on and 12 hr off at 25°C and then transferred to constant darkness (DD). 
Locomotor activities were recorded in 1 min bins using the Drosophila Activity Monitor (DAM) system 
(TriKinetics). Behavioral data collected from the first to the 7th DD cycle were extracted in 30 min bins 
and analyzed to determine the free-running period length and power of rhythmicity in individual flies 
using the ClockLab analysis software (Actimetrics). The confidence interval of the chi-square 
periodogram was set to 0.05 with the testing range of period lengths from 14 hr to 34 hr. The power of 
rhythmicity (P-S) was calculated by subtracting a Significance value (the minimum measurement 
considered rhythmic at a given period length with the confidence interval) from a Power value (the 
observed rhythmicity measurement at the given period length). Flies were defined as rhythmic if their 
power of rhythmicity values were greater than 10. All the genotypes were tested in multiple behavioral 
runs. Per each genotype, circadian periods were averaged from rhythmic flies only whereas the power 
of rhythmicity values were averaged from all the flies tested. The averaged locomotor activity profiles 
were analyzed using Microsoft Excel. 
 
RNA interference and RNA-tethering assays in S2 cells 
S2 cell culture and transient transfection using Effectene reagent (Qiagen) were performed as described 
previously [46]. For RNAi-mediated depletion experiments, double-stranded RNAs (dsRNAs) against 
each target gene were in vitro transcribed using MEGAscript kit according to the manufacturer’s 
instructions (Ambion). S2 cells on 6-well plates were incubated with 15 µg of each purified dsRNA for 
2 days before they were transfected with an appropriate set of expression vectors. Cells were harvested 
at 48-hours after transfection and lysed for the subsequent biochemical analyses and luciferase reporter 
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assays. Dual luciferase assays for RNA-tethering experiments were performed according to the 
manufacturer’s instructions (Promega) as described previously [46]. 
 
DNA constructs 
cDNAs corresponding to the amino acids 1-267 or 268-459 of ME31B protein were PCR-amplified and 
replaced the full-length cDNA in pAc5.1B-EGFP-DmMe31B (a gift from E. Izaurralde) [144] to 
express EGFP-fused ME31B-N or ME31B-C proteins, respectively. cDNA corresponding to the amino 
acids 909-1560 of NOT1 protein was PCR-amplified from a full-length NOT1 cDNA and inserted into 
pAc5.1B-lN-HA (gifts from E. Izaurralde) (Addgene plasmid #21302) to express lN-fused NOT1 SD 
protein in the RNA-tethering assay. DDX6 and hLSM12 cDNAs were reverse-transcribed and 
amplified from total RNAs in a human breast cancer cell line MCF-7, and cloned into pAc5.1/EGFP or 
pAc5.1/3xHA to express EGFP- or HA-tagged proteins, respectively. hATXN2-N cDNA 
corresponding to the amino acids 1-511 of wild-type hATXN2 protein was similarly amplified from a 
human ATXN2 cDNA (a gift from A.D. Gitler) [59] and cloned into pAc5.1/V5-His (Invitrogen) to 
express V5-tagged protein. To bacterially express and purify GST- or His-tagged recombinant proteins, 
cDNAs were cloned into pGEX4T-1 (GE Healthcare) or a modified pDuet vector (a gift from C. Lee), 
respectively. S2 expression vectors for ATX2-3F, ATX2DPAM2-3F, ATX2-N-3F, TYF-C5-3F, 
TYFΔC5-3F, MS2-V5, TYF-MS2-V5, and RLUC; and RNA-tethering reporters including 
pAc5.1/5UTR-FLUC-3UTR-6xBS, pAc5.1- FLUC-5BoxB, pAc5.1-FLUC-5BoxB-HhR, and pAc5.1-
FLUC-5BoxB-HSL (gifts from E. Izaurralde) have been described previously [45, 46, 145]. 
The nucleotide sequences for LSM12 and ATXN2 short hairpin RNAs (shRNAs) were selected 
from a pre-designed library (Dharmacon). A control shRNA harbored a nucleotide sequence (5’-TCC 
TAA GGT TAA GTC GCC CTC-3’) that did not target any mammalian transcripts. Oligonucleotides 
encoding each shRNA were synthesized (Macrogen) and sub-cloned into pLKO.1 (a gift from B. 
Weinberg; Addgene plasmid #8453) for the production of recombinant lentiviruses. The nucleotide 
sequences for EPAC1 small interfering RNAs (siRNAs) were similarly selected from the pre-designed 
library (Dharmacon). EPAC1 siRNAs and non-targeting control siRNA (5’-CCU CGU GCC GUU 
CCA UCA GGU AGU U-3’) were synthesized (Genolution), dissolved in PBS, and stored at -20°C 
before use. A small guide RNA (sgRNA) sequence (5’-GAC GTG AGT TGG GAT CGG AG-3’) for 
the CRISPR/Cas9-mediated deletion of the LSM12 locus was designed using CHOPCHOP 
(https://chopchop.rc.fas.harvard.edu). The oligonucleotide encoding LSM12 sgRNA was synthesized 
(Macrogen) and sub-cloned into pRGEN-U6-sgRNA and pHRS (ToolGen) for the expression of LSM12 
sgRNA and the hygromycin B-resistance reporter gene, respectively. Full-length cDNAs encoding 
ATXN2, EPAC1, LSM12, or RAN proteins were PCR-amplified from pcDNA6-ATXN2-22Q (a gift 
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from A. Gitler), pEYFP-N3-EPAC1 (a gift from X. Cheng; Addgene plasmid #113110) or SH-SY5Y 
cDNA samples, respectively, and then sub-cloned into a modified pcDNA3.1 (pcDNA-3xnF) for the 
expression of C-terminal triple-FLAG fusion proteins. Poly(GR)-encoding cDNA (a gift from D. Ito) 
was sub-cloned into a modified pcDNA3.1 (pcDNA-GFP) vector for the expression of N-terminal GFP 
fusion proteins. RPL10A-encoding cDNA was PCR-amplified from SH-SY5Y cDNA samples and sub-
cloned into a modified pcDNA-GFP vector containing a hygromycin B-resistance gene for the selection 
of cells stably expressing N-terminally GFP-fused RPL10A proteins. Sub-regions of the EPAC1 locus 
were PCR-amplified from SH-SY5Y genomic DNA samples. The DNA fragments corresponding to 
EPAC1 5’ UTR or 3’ UTR were sub-cloned into a modified pcDNA 3.1 (pcDNA-NLUC) vector for the 
expression of NLUC-encoding UTR reporter transcripts. The DNA fragment corresponding to an 
EPAC1 promoter region was sub-cloned into a modified pGL2 basic (pGL2-NLUC) vector for the 
NLUC reporter expression by the EPAC1 promoter activity. FLUC-encoding cDNA was sub-cloned 
into pcDNA3.1 for the expression of a normalizing control reporter along with the NLUC reporters. S-
GFP was a gift from M.S. Hipp [146]. S-tdT-encoding cDNA (a gift from J. D. Rothstein) was sub-
cloned into pcDNA3.1. Lentiviral vectors for overexpression of LSM12 or EPAC1 were constructed by 
the Gateway cloning pENTR-Ubiquitin C promoter (Addgene plasmid #45959) and modified pENTR4-
FLAG entry vector (Addgene plasmid #17424) harboring either LSM12 or EPAC1 cDNA into pCWX-
DEST destination vector (Addgene plasmid #45957). 
 
Production of recombinant lentiviruses and establishment of stable cell lines 
293T cells were co-transfected with viral packaging plasmids (ViraPower Lentiviral Packaging Mix; 
Invitrogen) and third-generation pLKO.1 lentiviral vector encoding control, LSM12, or ATXN2 shRNA. 
Cell culture medium containing recombinant lentiviruses was harvested 48 and 72 hours after 
transfection. SH-SY5Y cells were then incubated with the lentiviral medium for 48 hours. Stably 
infected cells were selected by replacing fresh media containing 1 µg/ml puromycin every three days 
for 2 weeks to establish a stable cell line. Lentiviral particles for LSM12 or EPAC1 overexpression 
were produced similarly as above and concentrated by ultracentrifugation at 25,000 rpm for 2 hours at 
4°C. 
 
Establishment of an LSM12-knockout cell line by CRISPR/Cas9-mediated deletion 
SH-SY5Y cells were co-transfected with pRGEN-Cas9-CMV, pRGEN-U6-LSM12 sgRNA, and pHRS-
LSM12 sgRNA reporter. Reporter-edited cells were selected by culturing in medium containing 500 
µg/ml hygromycin B for 2 weeks. Individual colonies were manually picked and seeded into 12-well 
plates containing hygromycin B-free media to establish independent cell lines. LSM12 expression in 
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each cell line was analyzed by immunoblotting total cell extracts with an anti-LSM12 antibody. Cell 
lines lacking detectable LSM12 expression were further analyzed, whereas those showing LSM12 
expression comparable to that of parental cells served as controls. 
 
Immunofluorescence assay  
SH-SY5Y cells were grown on coverslips and then fixed in phosphate-buffered saline (PBS) containing 
3.7% formaldehyde at 25°C for 15 minutes. NPCs were seeded on Matrigel-coated coverslips. Twenty-
one days after neuronal differentiation from NPC, iPSNs were fixed similarly as above. After two 
washes with PBS, fixed cells were permeabilized with PBS containing 0.1% Triton X-100 (PBS-T) at 
4°C for 15 minutes, followed by two washes with PBS. Permeabilized cells were blocked with PBS-T 
containing 1% bovine serum albumin at 25°C for 30 minutes and then incubated with primary 
antibodies diluted in blocking buffer containing 0.05% sodium azide at 4°C for 1 day. The primary 
antibodies used in immunostaining were mouse anti-RAN (1:1000; Santa Cruz Biotechnology), mouse 
anti-G3BP1 (1:2000; Santa Cruz Biotechnology), mouse anti-FLAG (1:2000; Sigma-Aldrich), rabbit 
anti-lamin B1 (1:1000; Proteintech), rabbit anti-G3BP1 (1:2000; Proteintech), mouse anti-PABPC1 
(1:2000; Santa Cruz Biotechnology), rabbit anti-ATXN2 (1:2000; Proteintech), guinea pig anti-MAP2 
(1:1000; Synaptic System), mouse anti-HB9 (1:1000; Developmental Studies Hybridoma Bank), and 
rabbit anti-ChAT (1:1000; Proteintech), rabbit anti-polyGR (1:250; Proteintech), rabbit anti-TDP43 
(1:1000; Proteintech), and rabbit anti-cleaved caspase-3 (1:400; Cell Signaling Technology). After 
incubation with primary antibodies, cells were washed twice with PBS-T for 5 minutes each and then 
incubated at 4°C for 1 day with secondary antibodies diluted 1:600 in PBS-T. Species-specific Alexa 
Flour 488-, 594-, or 647-conjugated anti-IgG antibodies were used as secondary antibodies for 
immunostaining (Jackson ImmunoResearch Laboratories). Nuclei were visualized by staining with 
Hoechst for 5 minutes, followed by washing twice with PBS-T. Stained samples were slide-mounted in 
VECTASHIELD antifade mounting medium (Vector Laboratories).  
 
Luciferase reporter assay 
SH-SY5Y cells on 12-well plates were co-transfected with 100 ng of EPAC1 NLUC reporter plasmid 
and 100 ng of FLUC control plasmid. Transfected cells were harvested 48 hours after transfection and 
lysed for luciferase assays using a Nano-Glo Dual Luciferase Assay kit (Promega) according to the 
manufacturer’s instructions. Luminescence from each cell lysate was measured using a GloMax 
Navigator microplate luminometer (Promega). 
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Translating ribosome affinity purification (TRAP) 
TRAP was performed as described previously [147] with minor modifications. Briefly, SH-SY5Y cells 
stably expressing GFP-RPL10A were collected and lysed in a lysis buffer (20 mM HEPES-KOH pH 
7.4, 150 mM KCl, 10 mM MgCl2, 1%(v/v) NP-40, 100 µg/ml cycloheximide, 1 mM dithiothreitol 
[DTT], 1 mM phenylmethylsulfonyl fluoride [PMSF], and 200 U/ml RNase inhibitor) at 4°C for 15 
minutes with gentle rocking. Lysates were first centrifuged at 2,000 ´ g for 5 minutes at 4°C, and the 
supernatant was collected and further clarified by centrifugation at 20,000 ´ g for 10 minutes at 4°C 
with gentle rocking. Pre-equilibrated Protein G magnetic beads (New England BioLabs) were added to 
the extracts and further incubated at 4°C for 1.5 hours with gentle rocking. The beads were washed four 
times with a wash buffer (20 mM HEPES-KOH pH 7.4, 350 mM KCl, 5 mM MgCl2, 1%(v/v) rNP-40, 
100 µg/ml cycloheximide, 1 mM DTT, 1 mM PMSF, and 200 U/ml RNase inhibitor) prior to RNA 
extraction. Input and translating ribosome-associated RNAs were purified using an RNeasy Mini kit 
(QIAGEN) according to the manufacturer’s instructions. 
Differential gene expression analysis by RNA sequencing  
Ribosomal RNA was depleted from 50 ng of purified RNA samples using an rRNA depletion kit (New 
England BioLabs). cDNA libraries for RNA sequencing were generated using a NEBNext Ultra 
Directional RNA Library Prep Kit for Illumina according to the manufacturer’s instructions (New 
England BioLabs). The quality of sequencing libraries, defined by RNA Integrity Number (RIN) values, 
was examined using a DNA1000 chip (Agilent) and Agilent Technologies 2100 Bioanalyzer. After 
quantification by qRT-PCR using SYBR Green PCR Master Mix (Applied Biosystems), an equimolar 
amount of index-tagged libraries was pooled into a single sample. Clusters were generated in the flow 
cell on the cBot automated cluster-generation system (Illumina). RNA sequencing was performed on a 
NovaSeq 6000 system (Illumina) with a 2x 100-bp read length (DNA Link). Sequence reads were first 
mapped to the reference genome (Human hg19) using Tophat (v2.0.13) [148, 149], yielding 50–75 
million mapped reads per sample. The aligned results were added to Cuffdiff (v2.2.0), and differentially 
expressed genes (DEGs) were identified using the Cuffdiff output file, “gene_exp.diff”.  
 
Immunoprecipitation (IP) and Cap pull-down assay 
For Drosophila S2 cells, Protein co-immunoprecipitation, m7-GTP pull-down, and RNA 
immunoprecipitation assays were performed as described previously [45, 46]. For protein analyses, 
immunoprecipitates and input fraction were dissolved by 6% or 9.5% SDS-PAGE, transferred to 
Protran nitrocellulose membranes (GE Healthcare), and incubated with a specific set of primary 
antibodies. SH-SY5Y cells on a 100-mm dish were collected and lysed in a lysis buffer (25 mM Tris-
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Cl pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM DTT, 0.5%(v/v) NP-40, and 1 mM PMSF) 
at 4°C for 15 minutes with gentle rocking. After clarification by centrifugation, 30 µl of soluble extracts 
were retained as input, and the remaining soluble extract was incubated with 2 µg of antibody or control 
IgG at 4°C for 1.5 hours with gentle rocking. Pre-equilibrated Protein G magnetic beads (New England 
BioLabs) were added to the extracts and further incubated at 4°C for 1.5 hours with gentle rocking. The 
beads were then washed five times in the same buffer. Input samples and immunoprecipitates were 
resolved by SDS-PAGE on 6.5% and 10% gels, then proteins in each gel were transferred to Protran 
nitrocellulose membranes (GE Healthcare) and incubated with a specific set of primary antibodies. The 
primary antibodies used in immunoblotting were rabbit anti-TYF (1:2,000 dilution), rabbit anti-LSM12 
(1:2,000 dilution, drosophila), rabbit anti-ATX2 (1:2,000 dilution), rabbit anti-PABP (1:5,000 dilution), 
rabbit anti-ME31B (1:2,000 dilution), rabbit and mouse anti-NOT1 (1:2,000 dilution; gifts from E. 
Wahle and M. Goetze), rat anti-TRAL (1:2,000 dilution; a gift from E. Izaurralde), rabbit anti- EIF4E 
and anti-EIF4G (1:3,000 dilution; gifts from E. Izaurralde), mouse anti-RAN (1:1000; Santa Cruz 
Biotechnology), mouse anti-importin b1 (1:1000; Santa Cruz Biotechnology), mouse anti-RANGAP1 
(1:1000; Santa Cruz Biotechnology), mouse anti-RANBP2 (1:1000; Santa Cruz Biotechnology), mouse 
anti-EPAC1 (1:500; Santa Cruz Biotechnology), rabbit anti-LSM12 (1:2000), rabbit anti-p-EIF2a 
(1:2000; Cell signaling), mouse anti-EIF2a (1:1000; Santa Cruz Biotechnology), mouse anti-tubulin 
(1:1000; Developmental Studies Hybridoma Bank), rabbit anti-ATXN2 (1:2000; Proteintech), rabbit 
anti-ATXN2L (1:2000; Medico), mouse anti-PABPC1 (1:1000; Santa Cruz Biotechnology), and mouse 
anti-FLAG (1:2000; Sigma-Aldrich), mouse anti-HA (1:2,000 dilution; gifts from J. Choe), rabbit anti-
GFP (1:1,000 dilution; Santa Cruz Biotechnology), and mouse anti-V5 (1:5,000 dilution; Thermo Fisher 
Scientific). Immunoreactive proteins were recognized by species-specific horseradish peroxidase-
conjugated secondary antibodies (Jackson Immuno Research Laboratories), with subsequent detection 
by Clarity Western ECL blotting substrate (Bio-Rad) using ImageQuant LAS 4000 (GE Healthcare). 
 
RNA immunoprecipitation 
Two hundred of fly heads were homogenized in a HEPES RIP buffer (20 mM HEPES pH 7.4, 150 mM 
NaCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40, 1 mM PMSF, 250 U/ml SUPERase-In, protease 
inhibitors), lysed at 4°C for 20 min with gentle rocking, and then clarified twice by centrifugation at 
4°C for 15 min per each. Total RNAs were directly purified from one fourth of the soluble extracts 
(served as input) using Trizol reagent (Thermo Fisher Scientific) and reverse-transcribed with random 
hexamers by M-MLV reverse transcriptase (Promega) according to the manufacturer’s instructions. The 
rest of head extracts were incubated with 2 mL of anti-ATX2 serum or pre-immune serum for 1.5 hr at 
4°C with gentle rocking. Pre-equilibrated Protein A magnetic beads were then added to the extracts and 
38 
incubated for additional 1.5 hr at 4°C with gentle rocking. The beads were washed five times with the 
same buffer. Immunoprecipitated RNAs were extracted with Trizol reagent (Thermo Fisher Scientific), 
precipitated by isopropanol and then reverse transcribed as described above.  
 
Quantitative image analysis  
Several fields of interest were randomly selected from each imaging sample, and their confocal images 
were individually obtained using an FV1000 microscope (Olympus) with identical imaging settings. 
The fluorescence intensities of confocal images were quantified using ImageJ software. For SG analysis, 
G3BP-positive cytoplasmic inclusions with fluorescence intensities above a threshold were unbiasedly 
scored as SGs using Image J. The total numbers of cells, SG-positive cells and SGs per field, as well as 
the diameter of individual SGs, were measured as described previously [150]. For nuclear poly(GR) 
granule analysis, the percentage of cells positive for nuclear poly(GR) granules per field and the number 
of nuclear poly(GR) granules per cell were manually scored. The relative distribution of S-GFP, S-tdT, 
TDP-43, or RAN protein between nucleus and cytoplasm (N/C ratio) was quantified by calculating the 
ratio of nuclear to cytoplasmic fluorescence from each reporter protein, anti-TDP-43 or anti-RAN 
antibody staining per cell, as described previously [146, 151]. 
 
Quantitative RNA analysis  
Total RNA was purified using the TRIzol reagent (Thermo Fisher Scientific) and digested with 
DNase I according to the manufacturer’s instructions (Promega). DNase I was subsequently removed 
by phenol-chloroform extraction. RNA samples were further purified by ethanol precipitation and 
reverse-transcribed using M-MLV reverse transcriptase (Promega) with random hexamers. cDNA 
samples were quantitatively analyzed using SYBR Green-based Prime Q-Mastermix (GeNet Bio) and 
gene-specific primers on a LightCycler 480 real-time PCR system (Roche). 
 
Quantification and statistical analysis 
Quantification procedures for all experimental analyses are described in figure legends and Materials 
and Methods above. IBM SPSS Statistics, Microsoft Excel, and GraphPad Prism 8 software were used 
for Student’s t-test, one-way analysis of variance (ANOVA), and two-way ANOVA with post hoc tests. 
The statistical details of experiments, including the number of experiments and samples analyzed, the 











Part 1. LSM12 and ME31B/DDX6 define distinct modes of 
post-transcriptional regulation by ATAXIN-2 protein complex 

















III-1-1. A genetic screen identifies Lsm12 and me31B important for circadian locomotor 
rhythms in Drosophila 
The translational regulator TYF employs ATX2 to activate the translation of the rate-limiting circadian 
clock gene per, thereby defining a post-transcriptional co-activator function for ATX2 in Drosophila 
circadian clocks [45, 46, 152]. The ATX2-dependent translation of PER is most evident in ~150 
circadian pacemaker neurons present in adult fly brains (Figure III-1-1A). These clock neurons display 
high-amplitude PER cycling with 24-hour periodicity. Genetic disruptions in Atx2 or tyf dampen PER 
expression in these cells, leading to long, weak locomotor rhythms in free-running conditions where no 
external time cues are provided but endogenous circadian clocks in animals govern their daily 
locomotor activities. Based on these findings, we herein sought to identify novel factors that are 
important for ATX2-dependent translation in the context of circadian behaviors.  
We first obtained flies in which transgenic RNA interference (RNAi) had been used to target a 
group of genes whose protein products are thought to be involved in the ATX2 homolog-containing 
complexes [153-155]. In each case, the RNAi transgene along with the RNAi-enhancing dicer-2 
transgene [156] was overexpressed in all canonical clock neurons and possibly a subset of clock-
relevant glia that express a circadian clock gene, timeless (tim) [157]. We determined if the individual 
RNAi-mediated depletions of these specific genes in the pacemaker neurons affected free-running 
locomotor behaviors under constant darkness (DD). We found that the transgenic depletion of CG15735, 
a Drosophila homolog of LSM12, caused long-period locomotor rhythms in two independent RNAi 
lines (Figure III-1-1B, C, and D). In addition, three RNAi lines against me31B, a Drosophila homolog 
of the ATP-dependent RNA helicase, DDX6/Rck/p54, exhibited poor rhythmicity (Figure III-1-1C, 
D). Moreover, Lsm12 or me31B RNAi expression in Pdf-expressing clock neurons was sufficient to 
significantly affect DD behaviors (Figure III-1-1D), as consistent with previous findings that PDF 





Figure III-1-1. A genetic screen identifies Lsm12 and me31B important for circadian locomotor 
rhythms in Drosophila. 
(A) A schematic diagram of ~150 circadian pacemaker neurons that display daily rhythmic clock gene 
expression in each hemisphere of adult fly brain. Large and small ventral lateral neurons (l-LNv and s-
LNv, respectively) express a circadian neuropeptide PDF important for the free-running behavioral 
rhythms in constant dark (DD). LNd, dorsal LN; 5th s-LNv, PDF-negative LNv; DN, dorsal neuron; 
LPN, lateral posterior neuron. (B) Lsm12 RNAi transgenes were pan-neuronally overexpressed by Elav-
Gal4 driver (Elav>). (C) The averaged actograms of TD2 control (n = 91), Lsm12 RNAi (v101762, n = 
48; T34666, n = 49), and me31B RNAi flies (T28566, n = 27; 4916R-2, n = 21) throughout the 
behavioral tests. White colors, L phases; grey colors, D phases. (D) Depletion of LSM12 or ME31B in 
PDF-expressing neurons is sufficient to affect circadian behaviors in DD. Circadian period (top) or 
power of rhythmicity (bottom) was determined in each genotype. Data represent mean ± SEM (n = 20-
91 male flies). PD2, Pdf-Gal4>UAS-DCR2. **P < 0.01, ***P < 0.001 to heterozygous controls as 







III-1-2. Lsm12 in circadian pacemaker neurons sustains 24 hr periodicity in locomotor 
behaviors 
To more definitively validate the effects of Lsm12 on circadian clocks, we generated genomic deletions 
of the Lsm12 locus by imprecise excision of a P element insertion (Figure III-1-2A). All of our Lsm12-
deletion alleles were homozygote-viable and yielded barely detectable expression of LSM12 protein in 
fly head extracts, as compared to an excision control allele (Lsm12Δ2) (Figure III-1-2A, B). However, 
we found that transcript levels of Lsm12 and its adjacent genes were differentially affected in Lsm12-
deletion mutants, reflecting the range of the genomic deletion (Figure III-1-2C). Nonetheless, all of 
the Lsm12-deletion flies exhibited long-period locomotor rhythms in DD (Figure III-1-3A), and thus 
phenocopied the Lsm12 RNAi flies. A deficiency allele harboring a larger chromosomal deletion failed 
to complement Lsm12-deletion alleles in trans-heterozygotes (Figure III-1-3B). It is therefore unlikely 
that the circadian defects observed in the Lsm12-deletion flies were due to effects of irrelevant genetic 
background.  
We established UAS-LSM12 transgenic flies that could overexpress LSM12 in combination 
with tissue-specific or inducible Gal4 drivers. When cryptochrome (cry)-Gal4 was used to overexpress 
LSM12 in circadian pacemaker neurons, no significant effect was seen in the free-running circadian 
behaviors of wild-type flies, but the long-period locomotor rhythms in Lsm12-deletion flies were 
rescued (Figure III-1-4). This further verifies that the circadian phenotypes observed in the Lsm12-
deletion mutants were indeed due to the genetic deficit in Lsm12 rather than the effects of other genes. 
In addition, we employed an Elav-GeneSwitch-Gal4 driver [159] to induce pan-neuronal 
overexpression of the LSM12 transgene by feeding wild-type or Lsm12-deletion flies with RU486-
containing food. This conditional LSM12 overexpression was sufficient to rescue the long periods seen 
in Lsm12 mutants (Figure III-1-5), supporting the idea that LSM12 expressed in adult fly neurons plays 
a relatively direct role in sustaining 24-hour periodicity. Together with the Lsm12 RNAi phenotypes 
above, these data convincingly demonstrate that Lsm12 expression in the circadian pacemaker neurons 





Figure III-1-2. A schematic diagram of Lsm12-deletion alleles. 
(A) A schematic diagram of Lsm12-deletion alleles and genomic regions amplified by each pair of 
primers used in our quantitative transcript analyses. (B) Head extracts from control (Lsm12Δ2) and 
Lsm12-deletion flies were immunoblotted with antibodies shown on the left. (C) Total RNAs were 
prepared from adult fly heads of control (Lsm12Δ2) and Lsm12 mutants. Abundance of each transcript 
was quantified by realtime RT-PCR and normalized to that of Tango4. Relative expression levels were 
then calculated by normalizing the relative abundance of each gene in Lsm12 mutants to that in control 
(Lsm12Δ2) flies (set as 1). Data represent mean ± SEM (n = 3-4). **P < 0.01, ***P < 0.001 as determined 







Figure III-1-3. Lsm12 in circadian pacemaker neurons sustains 24-hour periodicity in circadian 
behaviors. 
A larger chromosomal deletion Df(1)ED7153 fails to complement Lsm12 mutant alleles. Circadian 
periods in DD behaviors were measured in male flies hemizygous for control (Lsm12Δ2) and Lsm12 
deletion alleles (A), or in female trans-heterozygotes with control (white bars) or Df(1)ED7153 (grey 
bars) (B). Data represent mean ± SEM (n = 15-63 male flies; n = 16-41 female virgin flies). n.s., not 
significant; *P < 0.05, ***P < 0.001 to Lsm12Δ2 or heterozygous controls as determined by one-way 




Figure III-1-4. LSM12 overexpression in cry-expressing clock neurons rescues long-period 
locomotor rhythms in Lsm12 mutants. 
(A) The averaged actograms per each genotype (n = 23–42) were double-plotted. White colors, L phases; 
gray colors, D phases. (B) Circadian periods were measured in control or Lsm12Δ3 flies with each 
combination of Gal4 and UAS transgenes. Data represent mean ± SEM (n = 23–48). n.s., not significant; 





Figure III-1-5. Adult-specific LSM12 overexpression restores locomotor rhythms with 24-hour 
periodicity in Lsm12 mutant flies. 
Locomotor activities in individual male flies were monitored during four LD cycles followed by seven 
DD cycles, averaged from 29-47 flies per each genotype, and double-plotted on the left. Where 
indicated, flies were fed on sucrose food containing 4% ethanol (vehicle control) or 0.5 mM RU486 
during the behavioral tests to induce LSM12 overexpression in all neurons by Elav-GeneSwitch (GS)-
Gal4 driver. White colors, L phases; grey colors, D phases. Circadian periods in free-running DD 
behaviors were measured in individual flies fed on food containing 4% ethanol control (white bars) or 
0.5 mM RU486 (grey bars) and averaged from 27-45 flies with detectable rhythmicity on the right. 
Error bars represent SEM. n.s., not significant; ***P < 0.001 to heterozygous Gal4 controls fed on 













III-1-3. Dampened PER cycling in circadian pacemaker neurons leads to long-period 
locomotor rhythms in Lsm12 mutants 
Dampened PER cycling in circadian pacemaker neurons, but not in whole fly heads, is a hallmark of 
the molecular defects that are observed in tyf mutants and Atx2 RNAi flies and cause their behavioral 
phenotypes [45, 46, 152]. Accordingly, we reasoned that PER might be limiting for 24-hour 
periodicity in Lsm12 mutants, in a manner similar to that seen in tyf mutants and Atx2 RNAi flies. 
Consistent with this hypothesis, insertion of a genomic per transgene (Figure III-1-6A) or PER 
overexpression in pacemaker neurons (Figure III-1-6B) partially but significantly rescued Lsm12 
mutant behaviors. Conversely, the overexpression of ATX2 or TYF failed to comparably rescue 
Lsm12 mutants, validating the specificity of the PER rescue. Importantly, modest depletion of LSM12 
in PDF neurons did not significantly affect the circadian periods of DD behaviors in control flies, but 
did exaggerate the period-lengthening effects of TYFΔC5, which is a dominant-negative form of TYF 
lacking the translation-activation domain [46] (Figure III-1-6C). Taken together, these results 
indicate that there is a phenotypic analogy between tyf and Lsm12 mutants, and their genetic 
interaction with respect to circadian periods, strongly suggesting that Lsm12 may be involved in the 












Figure III-1-6. Dampened PER expression causes long-period locomotor rhythms in Lsm12 
mutants. 
(A) A genomic per transgene rescues long-period locomotor rhythms in Lsm12 mutants. Control 
(Lsm12Δ2) or Lsm12 mutant virgins were crossed to a per transgenic line harboring a ~13.2 kb wild-
type per locus (p{13.2per-HAHis}). Circadian periods in DD locomotor rhythms were measured from 
their male progeny. Data represent mean ± SEM (n = 29-63). n.s., not significant; ***P < 0.001 as 
determined by one-way ANOVA, Tukey post-hoc test. (B) PER overexpression in circadian pacemaker 
neurons rescues long-period locomotor rhythms in Lsm12 mutants. PER, ATX2 or TYF was 
overexpressed in cry-expressing clock neurons of control or Lsm12 mutant flies. Data represent mean 
circadian periods in DD locomotor rhythms ± SEM (n = 25-42). (C) Depletion of LSM12 but not 
ME31B exaggerates the period-lengthening effects of TYF dominant-negative (TYFΔC5). TYFΔC5 
transgene was overexpressed in PDF-expressing neurons of control, me31B RNAi or Lsm12 RNAi flies. 











III-1-4. me31B supports behavioral rhythmicity via the ATX2 pathway 
In contrast with Lsm12-deletion mutants that we have generated for the genetic analyses above, partial 
deletions of the me31B locus cause homozygous lethality during development [160]. Accordingly, we 
further examined me31B RNAi flies to elucidate possible mechanisms that might underlie ME31B-
dependent clock regulation. ME31B depletion in circadian pacemaker neurons dampened the rhythm 
amplitude in circadian locomotor behaviors (Figure III-1-1). To determine if me31B effects on the 
circadian rhythmicity are Atx2-dependent, we investigated their genetic interaction in locomotor 
behaviors. ME31B depletion in circadian pacemaker neurons by a relatively weak cry-Gal4 driver 
decreased the behavioral rhythmicity very modestly (Figure III-1-7). However, the me31B RNAi 
phenotype was significantly enhanced by the co-expression of Atx2 RNAi transgene while circadian 
behaviors in wild-type backgrounds were not impaired by the same degree of ATX2 depletion. We 
failed to detect genetic interaction between me31B and tyf in circadian behaviors (Figure III-1-6C). In 
addition, PER overexpression rescued long-period rhythms but not the rhythmicity phenotype in Atx2 
RNAi flies [46]. Taken together, the non-additive effects of Atx2 and me31B suggest that they may act 
together in the same genetic pathway to sustain circadian rhythmicity, likely via the clock output from 












Figure III-1-7. Modest depletion of ATX2 and ME31B non-additively dampens the rhythm 
amplitude in circadian behaviors.  
Atx2 and me31B RNAi transgenes were overexpressed in cry-expressing clock neurons by the relatively 
weak cry-Gal4. Data represent mean ± SEM (n = 21–69). n.s., not significant; ***p < 0.001 to controls 














III-1-5. LSM12 and ME31B associate with the ATX2-TYF complex 
To elucidate the molecular mechanisms underlying the genetic interactions of Lsm12 and me31B with 
the ATX2-TYF pathway, we biochemically analyzed the endogenous ATX2-TYF protein complex 
using a series of immunoprecipitation (IP) experiments. IP using anti-ATX2 or anti-TYF antibodies, 
but not pre-immune antibody, co-purified LSM12 and PABP proteins along with the ATX2-TYF 
complex from soluble extracts of Drosophila S2 cells (Figure III-1-8A). The specific association of 
LSM12 with the ATX2-TYF complex was validated by our observation that TRAILER HITCH (TRAL), 
a Drosophila homolog of LSM14, was not enriched in the ATX2 or TYF IPs. RNase treatment did not 
disrupt the co-purification of LSM12 with the ATX2-TYF complex (Figure III-1-8B), excluding the 
possibility that intermediate RNA molecules mediate the nonspecific association of these proteins. To 
assess the ATX2-TYF complex present in clock-related neurons, we expressed epitope-tagged TYF or 
LSM12 proteins in tim-expressing circadian pacemaker neurons, and affinity-purified the TYF- or 
LSM12-associating protein complexes from fly head extracts. Under these conditions, FLAG-tagged 
TYF efficiently pulled down the endogenous LSM12, ATX2, and PABP proteins (Figure III-1-9A). 
Deletion of the translation-activation domain of TYF (TYFΔC5) abolished its associations with the 
ATX2-PABP complex as well as LSM12, suggesting that LSM12 may be involved in TYF-dependent 
translational activation. Similarly, IP of FLAG-tagged LSM12 confirmed that LSM12 specifically 
associated with the ATX2-TYF complex in circadian clock neurons (Figure III-1-9B). These data 
demonstrate that LSM12 is a core component of the ATX2-TYF co-activator complex in vivo and in 
vitro. 
In contrast, we failed to detect any enrichment of endogenous ME31B proteins in the IPs 
performed with the anti-ATX2 or anti-TYF antibodies in S2 cell extracts (Figure III-1-8A). Given that 
DDX6 (a mammalian homolog of ME31B) is known to form diverse, biochemically distinct protein 
complexes [161, 162], we speculated that while a subpopulation of ME31B proteins might interact with 
the ATX2-TYF complex, the enrichment of ME31B might not be readily detectable in the IPs of the 
endogenous ATX2-TYF complex. To verify this possibility, we overexpressed epitope-tagged ME31B 
proteins and performed a reciprocal IP in S2 cells. EGFP-fused ME31B, but not EGFP itself, efficiently 
co-purified all the endogenous components of the ATX2-TYF complex (including LSM12) in an 
RNase-insensitive manner (Figure III-1-10A). Deletion mapping revealed that the ATX2-LSM12-TYF 
complex associated with the C-terminal RecA-like domain of the ME31B protein (ME31B-C) (Figure 
III-1-10B) [144, 163]. We note that the N-terminal deletion in ME31B protein modestly weakened the 
interaction between ME31B and the ATX2-LSM12-TYF complex. However, the same deletion did not 
impact on the binding of PABP or NOT1 to the ME31B complex, likely indicating that the association 
of the ATX2-LSM12-TYF complex with ME31B might be independent of the other proteins.  
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Finally, we confirmed that the ATX2-ME31B/DDX6 and ATX2-LSM12 interactions are 
conserved between the human homologs of these proteins, as exhibited by heterologous expression of 
these proteins in S2 cells (Figure III-1-11A). Moreover, human LSM12 (hLSM12) associated with the 
DDX6-containing protein complex only in the presence of N-terminal human ATX2 (hATXN2-N) 
(Figure III-1-11B), suggesting that ATX2 may function as a platform for the non-competitive assembly 
of LSM12 and ME31B/DDX6. Taken together, these data support the notion that LSM12 and ME31B 
interact with the ATX2-TYF complex, although their association with the ATX2-TYF complex might 


















Figure III-1-8. LSM12 associates with the ATX2-TYF complex in Drosophila S2 cells. 
(A) Soluble S2 cell extracts were immunoprecipitated by pre-immune control, anti-ATX2, or anti-TYF 
antibodies. Purified immunoprecipitation (IP) complexes were resolved by SDS-PAGE and 
immunoblotted with specific antibodies (right). Input, 4.5% of soluble extracts used in each IP. (B) 
Where indicated, soluble extracts were treated with 0.5 mg/ml of RNase A prior to the 










Figure III-1-9. The translation-activation domain of TYF (TYF-C5) is necessary for the 
association with ATX2 and LSM12 in circadian pacemaker neurons. 
FLAG- tagged TYF, TYFΔC5, or LSM12 proteins were expressed in tim-expressing clock neurons of 









Figure III-1-10. The C-terminal RecA-like domain of ME31B associates with the ATX2-TYF 
complex. 
S2 cells were transfected with expression vectors for EGFP or EGFP-ME31B fusion proteins as 
indicated at the top. Soluble extracts were prepared at 48 hr after transfection and immunoprecipitated 
by anti-GFP antibody. Where indicated, the soluble extracts were treated with 0.5 mg/ml of RNase A 
prior to the immunoprecipitation (IP). The IP complexes were analyzed similarly as above. Arrowhead 







Figure III-1-11. Biochemical association of LSM12 and ME31B/DDX6 with the ATX2-TYF 
complex is non-competitive and conserved between Drosophila and human.  
S2 cells were transfected with the indicated combinations of expression vectors for (A) GST-V5, 
hATXN2-N-V5 and hLSM12-HA or (B) EGFP, EGFP-DDX6, hATXN2-N-V5 and hLSM12-HA. 
Soluble extracts were prepared at 48 hours after transfection and immunoprecipitated by anti-V5 or 

















III-1-6. LSM12 is a molecular adaptor that mediates the ATX2-TYF interaction 
To dissect the molecular architecture of the ATX2-TYF co-activator complex, we first examined how 
Lsm12 mutation affected the assembly of the ATX2 complex in vivo. To this end, we compared the 
biochemical composition of the endogenous ATX2 complex in wild-type and Lsm12-deletion mutants 
in co-IP experiments. Importantly, the enrichment of TYF in ATX2 IPs from fly head extracts was 
diminished by Lsm12 mutation whereas the lack of LSM12 protein did not affect the ATX2-PABP 
interaction (Figure III-1-12A). Moreover, the association of the ATX2 complex with clock gene 
mRNAs was comparable between wild-type and Lsm12 mutants (Figure III-1-12B), consistent with 
our previous findings that the RNA-binding activity of the ATX2 complex is PABP-dependent but 
TYF-independent [46]. To confirm these in vivo data, we overexpressed the translation-activation 
domain of TYF (TYF-C5) in transiently transfected S2 cells and used it as a bait protein to pull down 
the endogenous ATX2 complex. In this reciprocal IP, the RNAi-mediated depletion of LSM12 
disrupted the interaction between ATX2 and TYF-C5 (Figure III-1-12C). These results clearly show 
that LSM12 is specifically necessary for the stable interaction between ATX2 and TYF. 
Eukaryotic mRNAs possess 7-methylguanosine (m7-GTP) at their 5’ ends. The recognition of 
this 5’-cap structure by specific translation initiation factors (e.g., eIF4E) protects mRNAs from de-
capping and degradation, and promotes ribosomal assembly and cap-dependent translational initiation 
[164-166]. We previously suggested that the mechanism of TYF-dependent translational activation 
might involve the association of TYF with the cap-binding complex [45]. Here, we questioned whether 
ATX2 or any specific ATX2-associating factor could be involved in this process. Cap pull-down assays 
using m7-GTP affinity columns confirmed that the ATX2-PABP complex associates with the 5’-cap 
independently of TYF, LSM12 or ME31B (Figure III-1-13A). Deletion of the PABP-interacting PAM2 
motif in ATX2 protein, however, abolished its 5’-cap association (Figure III-1-13B). Since PABP 
interacts with the cap-associating translation initiation factor eIF4G [165], it is likely that PABP links 
ATX2 to eIF4G in the cap-binding complex. While ATX2 depletion post-transcriptionally decreased 
the protein levels of TYF and LSM12, ATX2-depleted S2 cells did not show any enrichment of TYF in 
the cap pull-down (Figure III-1-13A). Importantly, LSM12 depletion alone was sufficient to 
specifically dissociate TYF from the cap-binding complex. These results support a model in which 
ATX2 may recruit TYF to the 5’-cap via LSM12 for TYF-dependent translation. Finally, we found that 
LSM12 depletion in S2 cells suppressed the TYF-dependent activation of reporter gene expression in a 
RNA-tethering assay (Figure III-1-14). Given our previous results showing that depletion of ATX2 
but not ME31B similarly abolished translational activation by RNA-tethered TYF [46], our data 
convincingly demonstrate that LSM12 acts as a TYF-specific molecular adaptor of the ATX2 complex 





Figure III-1-12. LSM12 is a TYF-specific molecular adaptor in the ATX2 complex. 
(A) Head extracts from control (Lsm12Δ2) and Lsm12 mutant flies (Lsm12Δ6) were immunoprecipitated 
with pre-immune control or anti-ATX2 antibodies. Purified immunoprecipitation (IP) complexes were 
resolved by SDS-PAGE and immunoblotted with specific antibodies (left). Input, 2.5% of soluble 
extracts used in each IP. (B) Lsm12 deletion does not affect the association of ATX2 with clock mRNAs. 
Wild-type control (Lsm12Δ2) and Lsm12 mutant flies (Lsm12Δ6) were collected at ZT16 in LD cycles. 
Their head extracts were immunoprecipitated with pre-immune control or anti-ATX2 antibodies. Total 
RNAs were purified from the IP complex as well as input, and quantitatively analyzed by realtime RT-
PCR. Abundance of each transcript in IP was normalized to that in input. Relative RNA enrichment 
were then compared among pre-immune IP from Lsm12Δ2 flies (lighter grey bars), anti-ATX2 IP from 
Lsm12Δ2 (darker grey bars) and Lsm12Δ6 flies (orange bars). Data represent mean (arbitrary units) ± 
SEM (n = 3). n.s., not significant; *P < 0.05, **P < 0.01, as determined by one-way ANOVA, Tukey 
post-hoc test  (C) LSM12 depletion disrupts the association of ATX2 with the translation-activation 
domain of TYF (TYF-C5). FLAG-tagged TYF-C5 or TYFΔC5 proteins were expressed in EGFP 













Figure III-1-13. Depletion of ATX2 or LSM12 abolishes the 5’-cap association of TYF. 
(A) Soluble extracts were prepared from dsRNA-treated S2 cells and incubated with m7-GTP affinity 
beads to purify the cap binding protein complexes. EIF4E and tubulin proteins were positive and 
negative controls, respectively. Input, 4.5% of soluble extracts used in each pull down. (B) PABP-
interacting motif 2 (PAM2) mediates the 5’-cap association of ATX2. S2 cells were transfected with 
the FLAG-tagged ATX2 expression vectors for wild-type (ATX2-3xFLAG) or PAM2 deletion 
(ATX2ΔPAM2-3xFLAG). Soluble extracts were incubated with either glutathione (GSH)- or m7GTP-
affinity beads to isolate protein complexes associating with the 5’-cap. EIF4G/EIF4E and TUBULIN 











Figure III-1-14. LSM12 depletion suppresses translational activation by RNA-tethered TYF. 
Firefly luciferase (FLUC) RNA reporter containing MS2-binding sites, renilla luciferase (RLUC) RNA 
reporter and MS2 fusion proteins (MS2 or TYF-MS2) were co-expressed in EGFP (white bars) or 
LSM12 (gray bars)-depleted S2 cells. Specific depletion of endogenous LSM12 protein was confirmed 
by immunoblotting (left). Dual luciferase reporter assays were performed at 48-hours after transfection. 
Activation fold was calculated by normalizing to the FLUC/RLUC value in EGFP-depleted cells 
expressing MS2. Data represent mean ± SEM (n = 5). n.s., not significant; ***P < 0.001 as determined 



















III-1-7. ATX2 associates with NOT1 in a ME31B-dependent manner and supports 
NOT1-mediated gene silencing 
The post-transcriptional activities of ME31B/DDX6 largely implicate mRNA decay and translational 
repression. In particular, the functional association of DDX6 with the CCR4-NOT deadenylase complex 
via a scaffold protein NOT1 suggests a role of ME31B/DDX6 in microRNA (miRNA)-dependent gene 
silencing [167-169]. These observations give rise to the possibility that ME31B and NOT1 
collaboratively contribute to the high-amplitude circadian rhythms via the clock output pathway. To 
genetically validate this hypothesis, we first examined effects of NOT1 depletion on the circadian clock 
function in transgenic flies. The RNAi-mediated depletion of NOT1 in PDF neurons dampened the 
rhythmicity in circadian locomotor behaviors (Figure III-1-15). This behavioral phenotype was 
significantly enhanced by the heterozygosity of hypomorphic Atx2 mutation, indicative of the genetic 
interaction between Atx2 and Not1 on the circadian rhythmicity. In addition, we note that simultaneous 
depletion of ME31B and NOT1 in PDF neurons more evidently dampened the free-running locomotor 
rhythms in the averaged actograms than each single depletion (Figure III-1-15A). 
To further validate the implication of NOT1 in the ATX2-ME31B pathway, we tested 
biochemical and functional interactions between NOT1 and the ATX2-ME31B complex in S2 cells. 
We first confirmed that the N-terminal 298 amino acids of the ATX2 protein (ATX2-N), which include 
the Lsm/Lsm-associated (Lsm/LsmA) domain, were sufficient to exhibit specific binding to NOT1 as 
well as all endogenous TYF, LSM12 and ME31B proteins (Figure III-1-16A) [46]. The ATX2-N does 
not include PAM2, and the enrichment of PABP in the ATX2-N IP was not evident, excluding the 
possible implication of PABP in the ATX2-NOT1 interaction. Importantly, ME31B depletion disrupted 
the association of ATX2-N with NOT1, but not with LSM12 and TYF. Given that ME31B depletion 
did not affect NOT1 levels, these data suggest that ME31B facilitates the selective assembly of the 
ATX2-NOT1 complex, differentiating its structural role from that of LSM12. 
To determine if the ATX2-ME31B complex modulates the post-transcriptional activity of 
NOT1, we employed the post-transcriptional activity of NOT1 silencing domain (SD; amino acids 909–
1,560). This region in NOT1 protein includes MIF4G domain for the direct binding to DDX6 and 
exhibits gene silencing activity in similar RNA-tethering assays [167-169]. We tested the activity of the 
NOT1 silencing domain (SD) with three types of RNA reporters with different 3’ ends (Figure III-1-
16B). A self-cleaving hammerhead ribozyme (HhR) and histone stem-loop (HSL) are two cis-elements 
that could block the polyadenylation at 3’ end of the RNA reporter molecules [145]. In addition, HSL 
but not HhR could promote the circularization of the RNA reporter molecules via the interaction 
between HSL-binding protein and translation initiation factors at 5’-cap. The expression of all three 
reporters were comparably suppressed by the RNA-tethered NOT1 SD (i.e., 24~42% of wild-type 
expression) as consistent with previous results [168]. Importantly, we found that depletion of ATX2 
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and ME31B, but not LSM12, significantly and specifically masked the repressive effects of the NOT1 
SD on the HSL-containing RNA reporter. These results reveal a novel role of the ATX2-ME31B 
complex in deadenylation-independent translational repression by NOT1. The phenotypic difference 
between HSL and HhR reporters also suggests that the ATX2-ME31B dependent activity of NOT1 
requires the intimate interaction between 5’-cap and 3’ end in polyA-deficient RNA molecules. Taken 
together, our data provide mechanistic insight into how the ATX2 complex could switch its post-


























Figure III-1-15. Not1 genetically interacts with Atx2 to regulate rhythmicity in circadian 
behaviors. 
(A and B) NOT1 depletion and the heterozygosity of hypomorphic Atx2 mutation (Atx2[0]/+) non-
additively dampens the rhythm amplitude in circadian behaviors. Data represent mean ± SEM (n = 28–
39). n.s., not significant; ***p < 0.001 to Pdf-Gal4 controls as determined by one-way ANOVA, 
Tukey’s post hoc test. (C) Not1 RNAi transgene was overexpressed by eye-specific GMR-Gal4 driver 
in transgenic flies. Head extracts were prepared from two independent samples and immunoblotted with 








Figure III-1-16. ATX2 associates with NOT1 in a ME31B-dependent manner and supports 
NOT1-mediated gene silencing 
(A) ME31B depletion disrupts the association of NOT1 with the ATX2 complex. (B) ATX2 or ME31B 
depletion de-represses gene silencing by RNA-tethered NOT1 silencing domain (SD). Firefly luciferase 
(FLUC) RNA reporters containing lN-binding sites (boxB), renilla luciferase (RLUC) RNA reporter 
and lN fusion proteins (lN or lN-NOT1 SD) were co-expressed in dsRNA-treated S2 cells as indicated 
at the top. Dual luciferase reporter assays were performed at 48-hours after transfection. Relative 
expression was first calculated per each dsRNA by normalizing to the FLUC/RLUC value in lN-
expressing S2 cells. The percentage of repression by the NOT1 SD was then calculated per each dsRNA 
by normalizing to the relative expression in dsEGFP-treated S2 cells (set as 100%). The polyadenylation 
(polyA-tail) and circularization of the three FLUC reporters are differentially affected by their 3’ ends 
(HhR, hammerhead ribozyme; HSL, histone stem-loop) as indicated at the bottom. Data represent mean 
± SEM (n = 3). n.s., not significant; **P < 0.01, ***P < 0.001 to dsEGFP control as determined by one-





Figure III-1-17. A two-pathway model for ATX2-dependent post-transcriptional regulation 
LSM12 supports ATX2-dependent translational activation of RBP (e.g., TYF)-specific mRNAs. On the 
other hand, ME31B/DDX6 implicates ATX2 in NOT1-dependent gene silencing on polyA-deficient 
mRNAs and possibly, in miRNA-mediated gene silencing. Note that Atx2 and me31B effects on the 





















Part 2. LSM12-EPAC1 defines a neuroprotective pathway that  



















III-2-1. LSM12 depletion attenuates SG formation upon arsenite-induced oxidative stress 
Given that SG assembly is suppressed by loss of ATXN2 function [65, 155, 170], we asked if ATXN2-
associated LSM12 plays a similar role in SG formation. We induced mild oxidative stress in the SH-
SY5Y human neuroblastoma cell line with 50 µM arsenite, and then visualized the formation of G3BP1- 
or PABPC1-positive SGs. Under these conditions, SG assembly underwent a gradual maturation 
process whereby the average size of SGs per cell became larger through fusion over 2 hours after 
incubation with arsenite (Figure III-2-1A). LSM12 depletion by stable transfection of short hairpin 
RNA (shRNA), however, decreased the relative proportion of SG-positive cells, suggesting that loss of 
LSM12 function may increase the threshold for initiating SG assembly. Further quantification revealed 
that each LSM12-depleted cell initially formed fewer SGs than control cells and displayed a smaller 
average size of SGs during maturation (Figure III-2-1B). The SG phenotypes in LSM12-depleted cells 
were insensitive to puromycin treatment that destabilizes polysomes and promotes SG formation in 
control cells (Figure III-2-2A) [171]. To further probe LSM12 effects on SG disassembly, we induced 
SG formation with a high dose of arsenite (500 µM) for 1 hour and then traced SG disassembly after 
the removal of arsenite from cell culture media (Figure III-2-2B, C). Under the acute oxidative stress, 
weaker effects of LSM12 depletion on SG formation persisted during SG disassembly and became 
undetectable 4 hours after recovery. LSM12 effects on SGs were relatively specific to arsenite-induced 
oxidative stress since SG formation under sorbitol-induced osmotic stress [172] was comparable 
between control and LSM12-depleted cells (Figure III-2-3A). These SG phenotypes in LSM12-
depleted cells also correlated with lower levels of EIF2α phosphorylation upon oxidative stress, but not 
upon other cellular stresses [173, 174] (Figure III-2-3B, C). 
In fact, LSM12 depletion modestly decreased endogenous levels of ATXN2 protein (Figure 
III-2-1C). We found that ATXN2 overexpression partially rescued the average number and size of 
arsenite-induced SGs in LSM12-depleted cells (Figure III-2-4). However, a lower percentage of SG-
positive cells in LSM12-depleted cells was not evidently rescued by ATXN2 overexpression, indicating 
more direct effects of LSM12 on the threshold for initiating SG assembly. ATXN2 depletion, on the 
other hand, did not affect endogenous levels of LSM12 protein (Figure III-2-1C) but caused an 
impairment in SG formation similar to that observed in LSM12-depleted cells (Figure III-2-1A, B). 
Moreover, we observed the non-additive effects of LSM12 and ATXN2 on arsenite-induced SG 
assembly, suggesting that these factors may act together in the same genetic pathway to regulate SG 




Figure III-2-1. LSM12 depletion attenuates SG formation upon arsenite-induced oxidative stress. 
(A) LSM12 and ATXN2 promote arsenite-induced SG assembly, likely via the same genetic pathway. 
Each cell lines were incubated with 50 µM sodium arsenite (NaAsO2) for the indicated time and then 
co-stained with anti-G3BP1 antibody (red), anti-PABPC1 antibody (green), and Hoechst 33258 (blue) 
to visualize SGs and the nucleus, respectively. (B) The percentage of SG-positive cells, the number of 
SGs per SG-positive cell, and the size of SGs were quantified using ImageJ software and averaged (n 
= 15–19 confocal images of random fields of interest obtained from 3 independent experiments; 
n = 329–1045 cells). Error bars indicate SEM. **P<0.01, ***P<0.001 to controlshRNA cells at a given 
time-point, as determined by two-way ANOVA with Tukey’s post hoc test. (C) Immunoblotting of total 
cell extracts from individual shRNA cell lines with anti-ATXN2, anti-LSM12, and anti-tubulin (loading 
control) antibodies. The abundance of each protein was quantified using ImageJ and normalized to that 
of tubulin. Relative protein levels were then calculated by normalizing to those in controlshRNA cells. 
Data represent means ± SEM (n = 3). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as 




Figure III-2-2. LSM12 depletion impairs SG assembly under arsenite-induced oxidative stress. 
(A) Puromycin treatment enhances arsenite-induced SG formation in controlshRNA cells, but not in 
LSM12shRNA cells. ControlshRNA and LSM12shRNA cells were pre-incubated with puromycin (5 µg/ml) or 
PBS (vehicle control) for 15 minutes before the induction of chronic oxidative stress (50 µM NaAsO2, 
2 hours). The percentage of SG-positive cells, the number of SGs per cell, and the size of SGs were 
quantified using ImageJ software and averaged (n = 10 confocal images obtained from 3 independent 
experiments; n = 713–939 cells). Error bars indicate SEM. n.s., not significant; *P < 0.05, **P < 0.01, 
***P < 0.001, as determined by two-way ANOVA with Tukey’s post hoc test. (B) LSM12 depletion 
altered the kinetics of SG disassembly during the recovery from acute oxidative stress. ControlshRNA and 
LSM12shRNA cells were incubated with 500 µM NaAsO2 for 1 hour and then washed with fresh media. 
Cells were fixed at the indicated time after the removal of NaAsO2.(C) The kinetics of SG disassembly 
were quantified similarly as above. Data represent means ± SEM (n = 8–10 confocal images obtained 
from 3 independent experiments; n = 388–740 cells). *P < 0.05, **P < 0.01, ***P < 0.001, as 




Figure III-2-3. Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced 
SG formation in LSM12-depleted cells.  
(A) LSM12 depletion does not suppress the SG assembly under sorbitol-induced osmotic stress. 
ControlshRNA and LSM12shRNA cells were incubated with 0.4 M sorbitol for the indicated time before co-
staining with anti-ATXN2 antibody (red), anti-G3BP1 antibody (green), and Hoechst 33258 (blue). (B, 
C) LSM12 depletion decreases the arsenite-induced phosphorylation of EIF2α. ControlshRNA and 
LSM12shRNA cells were incubated with 50 µM NaAsO2, 1 µM thapsigargin (Tg), or 0.4 M sorbitol for 
the indicated time before harvest. Whole-cell lysates were immunoblotted with specific antibodies (left). 
Relative levels of EIF2α phosphorylation were calculated by normalizing the ratio of phospho-EIF2α 
to EIF2α protein levels per condition to that in control cells with no chemical treatment. Data represent 




Figure III-2-4. Overexpression of LSM12, but not ATXN2, restores arsenite-induced SG 
assembly in LSM12-depleted cells.  
ControlshRNA and LSM12shRNA cells were transfected with an expression vector for FLAG, FLAG-tagged 
LSM12, or FLAG-tagged ATXN2. Arsenite-induced SG assembly was quantified 48 hours after 
transfection. Data represent means ± SEM (n = 15–16 confocal images obtained from 3 independent 
experiments; n = 200–820 cells). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001 to 
controlshRNA cells expressing FLAG at a given time-point, as determined by two-way ANOVA with 









III-2-2. LSM12 depletion disrupts the RAN gradient and impairs NCT upon oxidative 
stress  
Emerging evidence indicates that SGs sequester cellular factors important for NCT and thereby interfere 
with NCT under diverse cellular or genetic stresses [126, 175]. Consistent with this, it has been shown 
that inhibition of SG assembly by ATXN2 depletion or treatment with integrated stress response 
inhibitor (ISRIB) rescues stress-induced disruption of NCT, identifying SG inhibition as a 
neuroprotective mechanism [126]. Given LSM12 effects on arsenite-induced SG assembly, we 
hypothesized that LSM12 depletion would mitigate the arsenite-induced impairment of NCT. To 
quantify NCT activity in SH-SY5Y cells, we employed a GFP (green fluorescent protein) reporter 
harboring both nuclear localization and export signals (shuttle-GFP/S-GFP) that predominantly 
localizes to the cytoplasm under basal conditions [146]. Any change in the ratio of nuclear to 
cytoplasmic S-GFP localization upon pharmacological or genetic perturbation would reflect 
quantitative alterations in NCT function. Consistent with previous findings [126], arsenite-induced 
oxidative stress significantly increased the nuclear fraction of S-GFP, whereas ATXN2 depletion or 
ISRIB treatment substantially blocked both SG formation and NCT defects upon oxidative stress 
(Figure III-2-5). Surprisingly, LSM12 depletion facilitated rather than hindered the nuclear 
translocation of S-GFP upon arsenite treatment (Figure III-2-6A). Moreover, ATXN2 depletion or 
ISRIB treatment failed to rescue the LSM12 phenotypes (Figure III-2-5). These effects were not 
specific to the S-GFP reporter since similar NCT defects were observed in LSM12-depleted cells 
expressing S-tdTomato (S-tdT), an independent NCT reporter that predominantly localizes to the 
nucleus under basal conditions [118] (Figure III-2-6B). These findings convincingly demonstrate that 
LSM12 sustains NCT in a manner independent of ATXN2 or SG assembly under oxidative stress 
conditions. 
RAN is an evolutionarily conserved, small GTPase that shuttles between the nucleus and 
cytoplasm in two alternating forms: GTP-bound and GDP-bound [104-106]. The opposing activities of 
RANGAP1 (RAN GTPase-activating protein 1) at the cytoplasmic side of the nuclear pore complex 
and of chromatin-associating RANGEF (RAN guanine nucleotide exchange factor, also known as 
RCC1), establish a steep nucleocytoplasmic gradient of RAN-GTP [107, 108]. The RAN-GTP/GDP 
state subsequently switches its binding affinity between nuclear transport factors, thereby defining the 
directional NCT of a given cargo protein via the nuclear pore complex [109]. Disruption of the 
nucleocytoplasmic RAN gradient has been observed in neurodegenerative diseases, such as C9ORF72-
ALS, Huntington’s disease, and Alzheimer’s disease [115, 116, 126]. We thus asked whether an 
abnormal RAN gradient would explain LSM12-depletion phenotypes in NCT. In control cells, arsenite-
induced oxidative stress increased the relative abundance of cytoplasmic RAN (Figure III-2-7). 
ATXN2 depletion or ISRIB treatment suppressed the arsenite-induced disruption of the RAN gradient, 
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consistent with previous observations [126]. On the other hand, LSM12 depletion itself was sufficient 
to disrupt the RAN gradient, whereas arsenite treatment had no additive effects on the RAN gradient in 
LSM12-depleted cells (Figure III-2-7). Consistent with our observations in NCT assays, ATXN2 
depletion or ISRIB treatment negligibly affected RAN phenotypes caused by LSM12 depletion. It is 
puzzling that LSM12 depletion disrupts the RAN gradient regardless of arsenite treatment while 
impairing NCT only under the oxidative stress. We speculate that there may be a compensating 
mechanism for LSM12 deficiency in non-stressed cells to sustain NCT. In this sense, LSM12 likely 
acts as a risk rather than a causative factor for NCT-relevant pathogenesis. Taken together, our data 
suggest that LSM12 has a role in establishing a basal RAN gradient, and these effects are likely distinct 










Figure III-2-5. LSM12 depletion impairs NCT under oxidative stress conditions in a manner that 
is independent of ATXN2 or SG assembly.  
(A) Individual shRNA cell lines were transfected with an expression vector for the S-GFP reporter. SG 
assembly was then quantified 48 hours after transfection. Transfected cells were co-stained with anti-
G3BP1 antibody (red) and Hoechst 33258 (blue). Where indicated, cells were incubated with 50 µM 
NaAsO2 or PBS (vehicle control) for 2 hours to induce oxidative stress. Phospho-EIF2α–dependent SG 
assembly was blocked by treating with 2 µM ISRIB for 3 hours before NaAsO2 incubation. DMSO was 
used as vehicle control for ISRIB. (B) NCT of S-GFP reporter proteins was quantified by calculating 
the ratio of nuclear to cytoplasmic (N/C) fluorescence in individual cells. Two-way ANOVA detected 
significant interaction effects of arsenite and ISRIB treatments on NCT only in controlshRNA cells (P = 
0.0004). Data represent means ± SEM (n = 100–137 cells from 3 independent experiments). n.s., not 






Figure III-2-6. LSM12 depletion exacerbates the impairment of NCT caused by arsenite-induced 
oxidative stress.  
(A) LSM12 depletion facilitates the nuclear mislocalization of S-GFP under oxidative stress conditions. 
ControlshRNA and LSM12shRNA cells were transfected with an S-GFP expression vector and then treated 
with 50 µM NaAsO2 for the indicated time before co-staining with anti-G3BP1 antibody (red) and 
Hoechst 33258 (blue). NCT of S-GFP reporter proteins was quantified as in Figure III-2-5B. Data 
represent means ± SEM (n = 123–127 cells from 3 independent experiments). *P < 0.05, **P < 0.01, 
***P < 0.001 to controlshRNA cells at a given time-point, as determined by Student’s t-test. (B) LSM12 
depletion facilitates the cytoplasmic mislocalization of S-tdT under oxidative stress conditions. Data 
represent means ± SEM (n = 103–118 cells from 3 independent experiments). n.s., not significant; 




Figure III-2-7. LSM12 depletion disrupts the nucleocytoplasmic RAN gradient in a manner that 
is independent of ATXN2 or SG assembly.  
(A) Cells were incubated with 2 µM ISRIB, 50 µM NaAsO2 or vehicle controls as described above, and 
then co-stained with anti-RAN antibody (red), anti-G3BP1 antibody (green), and Hoechst 33258 (blue). 
(B) The relative distribution of endogenous RAN proteins was quantified by calculating the ratio of 
nuclear to cytoplasmic (N/C) fluorescence. Two-way ANOVA detected significant interaction effects 
of arsenite and ISRIB treatments on the RAN gradient only in controlshRNA cells (P < 0.0001). Data 
represent means ± SEM (n = 95–104 cells from 3 independent experiments). n.s., not significant; 







III-2-3. LSM12 depletion facilitates the nuclear accumulation of C9ORF72-derived 
poly(GR) protein and exacerbates its pathogenic effects  
Given that pathogenic proteins implicated in ALS/FTD disrupt NCT via induction of SG formation 
[126], we wondered if the loss of LSM12 function would exacerbate these cellular processes, which are 
involved in neurodegeneration and possibly normal aging [113]. To test this possibility, we employed 
C9ORF72-derived poly(GR) protein translated from a codon-optimized synthetic cDNA encoding 100 
GR repeats [176]. Since poly(GR) protein localizes to NPM1-positive nucleoli and causes nucleolar 
stress [98-100], we tested whether LSM12 contributed to the nucleolar assembly of poly(GR) granules 
as well as poly(GR)-induced SG. LSM12 depletion significantly increased the relative proportion of 
cells harboring poly(GR)-induced SGs (Figure III-2-8). This contrasted with LSM12-depletion 
phenotype in that of cells harboring arsenite-induced SGs, further indicating the stress-specific effects 
of LSM12 on SG assembly. Nonetheless, the smaller G3BP-positive SGs in LSM12-depleted cells likely 
indicates a role for LSM12 in the maturation process of poly(GR)-induced SGs, similar to that observed 
in arsenite-induced SGs. LSM12 depletion caused more striking effects on the formation of nuclear 
poly(GR) granules. Control cells gradually accumulated poly(GR) protein in nucleolar granules after 
the transient transfection of cells with the poly(GR) expression vector (Figure III-2-8). LSM12 
depletion remarkably facilitated this process and increased the number of nuclear poly(GR) granules 
per cell. 
We next examined if these LSM12-depletion phenotypes led to any alterations in poly(GR) 
toxicity. Overexpression of poly(GR) protein in control cells disrupted NCT in an ISRIB-sensitive 
manner (Figure III-2-9), supporting that poly(GR) effects on NCT require SG formation [126]. By 
contrast, ISRIB treatment failed to rescue poly(GR)-induced impairment of NCT in LSM12-depleted 
cells, an effect similar to that of LSM12 on NCT under oxidative stress conditions. We further found 
that poly(GR) overexpression disrupted the integrity of the nuclear envelope (Figure III-2-10A). 
Abnormalities of the nuclear lamina induced by poly(GR) overexpression were more severe in LSM12-
depleted cells than control cells, indicating a strong correlation between the presence of nuclear 
poly(GR) granules and abnormal morphology of the nuclear envelop (Figure III-2-10B, C). We 
observed comparable phenotypes in a cell line harboring a CRISPR/Cas9-mediated deletion in the 
LSM12 genetic locus (Figure III-2-10D, E, and F). Taken together, these results suggest that LSM12 




Figure III-2-8. LSM12 depletion suppresses the maturation of poly(GR)-induced SGs but 
promotes the nuclear accumulation of poly(GR) granules.  
(A) ControlshRNA and LSM12shRNA cells were transfected with a GFP-GR100 expression vector and then 
co-stained with anti-G3BP1 antibody (red) and Hoechst 33258 (blue) at the indicated time after 
transfection. (B) The assemblies of poly(GR)-induced SGs and nuclear poly(GR) granules were 
quantified as in Figure III-2-1. Data represent means ± SEM (n = 23–25 confocal images obtained 
from 3 independent experiments; n = 424–513 GFP-GR100–positive cells). n.s., not significant; 









Figure III-9. ISRIB treatment suppresses the poly(GR)-induced disruption of NCT in control cells, 
but not in LSM12-depleted cells. 
(A) ControlshRNA and LSM12shRNA cells were co-transfected with expression vectors for S-GFP and 
FLAG-GR100. Where indicated, cells were incubated with 2 µM ISRIB or DMSO (vehicle control) for 
5 hours and then co-stained with anti-FLAG antibody (red) and Hoechst 33258 (blue) 48 hours after 
transfection. (B) NCT of S-GFP reporter proteins was quantified as in Figure III-2-5B. Data represent 
means ± SEM (n = 142–166 cells from 3 independent experiments). n.s., not significant; ***P < 0.001, 






Figure III-2-10. LSM12 depletion or LSM12 depletion exacerbates poly(GR)-induced disruption 
of the nuclear lamina.  
(A) Control shRNA and LSM12shRNA cells were transfected with an expression vector for GFP or GFP-
GR100 and then co-stained with anti-lamin B1 antibody (red) and Hoechst 33258 (blue) to visualize 
nuclear envelope morphology 48 hours after transfection. Yellow arrows indicate GFP-GR100–positive 
cells with severe disruption of the nuclear lamina. (B) Control cells expressing GFP-GR100 were scored 
for nuclear poly(GR) granules and abnormal morphology of the nuclear lamina. The relative 
percentages of cells with severe nuclear laminar disruption were averaged from confocal images of six 
random fields of interest per condition (n = 55–69 GFP-GR100–positive cells from 3 independent 
experiments). Error bars indicate SEM. ***P<0.001, as determined by Student’s t-test. (C) The relative 
percentages of controlshRNA and LSM12shRNA cells with severe nuclear lamina disruption were quantified 
as described above. Data represent means ± SEM (n = 10 confocal images obtained from 3 independent 
experiments; n = 183–297 GFP– or GFP-GR100–positive cells). n.s., not significant; ***P < 0.001, as 
determined by two-way ANOVA with Tukey’s post hoc test. (D) Control and LSM12KO cells were 
transfected and visualized as (A). (E) The assembly of nuclear poly(GR) granules was quantified as in 
Figure III-2-1. Data represent mean ± SEM (n = 15–17 confocal images obtained from 3 independent 
experiments; n = 403–418 GFP-GR100–positive cells). ***P < 0.001, as determined by Student’s t-test. 
(F) Data represent means ± SEM (n = 18–19 confocal images obtained from 3 independent experiments; 
n = 366–413 GFP– or GFP-GR100–positive cells). n.s., not significant; ***P < 0.001, as determined by 
two-way ANOVA with Tukey’s post hoc test. 
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III-2-4. An LSM12V135I mutant allele exhibits dominant-negative effects on the RAN 
gradient 
Large-scale genome-wide association studies have revealed an abundance of low-frequency genetic 
variants associated with ALS patients [177-179]. This is also the case for ALS-associated LSM12 loci, 
where several rare point mutations in the LSM12 coding sequence were detected 
(http://databrowser.projectmine.com/). Given our observation that LSM12 suppresses the nuclear 
assembly of ALS-relevant poly(GR) protein and its pathogenic effects, we hypothesized that some of 
these LSM12 variants might display loss-of-function phenotypes, explaining their presence in ALS 
patients. We, therefore, overexpressed either wild-type or point mutants of LSM12 in control or LSM12-
deleted cells and assessed their NCT-related functional activities.  
We first confirmed that disruption of NCT upon arsenite-induced oxidative stress was more 
severe in LSM12-deleted cells than control cells (Figure III-2-11), consistent with LSM12-depletion 
phenotypes (Figure III-2-5). Overexpression of wild-type LSM12 rescued LSM12-deletion phenotypes 
in NCT, whereas LSM12V135I, one of the LSM12 variants observed in ALS patients, failed to do so. In 
fact, LSM12V135I overexpression was sufficient to impair NCT in both control and LSM12-deleted cells 
regardless of arsenite treatment (Figure III-2-11). Since LSM12 deletion did not affect NCT in control 
cells not treated with arsenite, LSM12V135I might have neomorphic effects on NCT possibly via genetic 
induction of oxidative stress. Overexpression of LSM12V135I, but not wild-type LSM12, also promoted 
the assembly of nuclear poly(GR) granules in control cells and increased the cell population that 
displayed poly(GR)-induced SGs (Figure III-2-12).  
Finally, we found that these NCT phenotypes were consistent with LSM12 effects on the RAN 
gradient. Cytoplasmic mislocalization of RAN in LSM12-deleted cells was restored by overexpression 
of wild-type LSM12 (Figure III-2-13). In contrast, LSM12V135I overexpression potently disrupted the 
RAN gradient in control cells, but it did not exaggerate the RAN phenotype in LSM12-deleted cells. 
Considering that overexpression of neither wild-type LSM12 nor LSM12V135I altered endogenous levels 
of LSM12 proteins in control cells (Figure III-2-14), these results indicate the dominant-negative 
effects of LSM12V135I mutant on establishing a RAN gradient. The LSM12V135I variant is detectable in 
other general databases for single nucleotide polymorphism in humans (e.g., 
https://www.ncbi.nlm.nih.gov/snp/rs1162569843). However, its low allele frequency did not allow us 
to determine whether or not this mutation is exclusively associated with ALS. Nonetheless, our genetic 





Figure III-2-11. Overexpression of LSM12V135I mutant protein impairs NCT.  
(A) Control and LSM12KO cells were co-transfected with expression vectors for S-GFP and FLAG-
tagged LSM12 (wild-type or LSM12V135I mutant). Transfected cells were treated with 50 µM NaAsO2 
or PBS (vehicle control) for 2 hours and then co-stained with anti-FLAG antibody (red) and Hoechst 
33258 (blue) 48 hours after transfection. (B) NCT of S-GFP reporter proteins was quantified as in 
Figure III-2-5B. Two-way ANOVA detected significant interaction effects of arsenite treatment and 
LSM12 deletion on NCT only in FLAG-expressing cells (P = 0.0026). Data represent means ± SEM 
(n = 119–138 cells from 3 independent experiments). n.s., not significant; ***P < 0.001, as determined 










Figure III-2-12. Overexpression of LSM12V135I mutant protein promotes the nuclear 
accumulation of poly(GR) granules. 
(A) SH-SY5Y cells were co-transfected with expression vectors for GFP-GR100 and FLAG-tagged 
LSM12 (wild-type or LSM12V135I mutant), and then co-stained with anti-FLAG antibody (red), anti-
G3BP1 antibody (magenta), and Hoechst 33258 (blue) 48 hours after transfection. (B) The assemblies 
of poly(GR)-induced SGs and nuclear poly(GR) granules were quantified as in Figure III-2-1. Data 
represent means ± SEM (n = 19 confocal images obtained from 3 independent experiments; n = 279–
327 GFP-GR100–positive cells). n.s., not significant; *P < 0.05, ***P < 0.001, as determined by one-










Figure III-2-13. Overexpression of LSM12V135I mutant protein disrupts the nucleocytoplasmic 
RAN gradient. 
(A) Control and LSM12KO cells were transfected with an expression vector for FLAG-tagged LSM12 
(wild-type or LSM12V135I mutant) and then co-stained with anti-RAN antibody (red), anti-FLAG 
antibody (green), and Hoechst 33258 (blue) 48 hours after transfection. (B) The nucleocytoplasmic 
RAN gradient was quantified as in Figure III-2-7. Data represent means ± SEM (n = 119–120 cells 
from 3 independent experiments). n.s., not significant; ***P < 0.001, as determined by two-way 












Figure III-2-14. LSM12V135I overexpression does not alter the relative levels of endogenous 
LSM12 protein.  
(A) SH-SY5Y cells were transfected with an expression vector for FLAG, LSM12-FLAG, or 
LSM12V135I-FLAG. Total cell extracts were prepared 48 hours after transfection and immunoblotted 
with anti-FLAG, anti-LSM12, anti-ATXN2, anti-PABPC1, and anti-tubulin (loading control) 
antibodies. Overexpression of wild-type LSM12, but not LSM12V135I, increased the relative levels of 
endogenous ATXN2 protein, consistent with low levels of endogenous ATXN2 protein in LSM12-
depleted cells (Figure III-2-1C). (B) The abundance of each protein was quantified as in Figure III-
2-1C. Data represent means ± SEM (n = 4). n.s., not significant; ***P < 0.001, as determined by one-














III-2-5. LSM12 post-transcriptionally up-regulates EPAC1 expression to sustain the RAN 
gradient for NCT and suppress poly(GR) toxicity 
To elucidate how LSM12 contributes to the establishment of a nucleocytoplasmic RAN gradient, we 
performed gene expression analyses using RNA sequencing. Given the role of LSM12 in translation 
[180], we compared LSM12-dependent changes in total mRNAs with changes in translating ribosome-
associated mRNAs (Figure III-2-15A). Among genes that were differentially expressed between 
control and LSM12-depleted cells, EPAC1 displayed low expression in either RNA analyses of LSM12-
depleted cells. Further independent analyses confirmed that both EPAC1 transcript and EPAC1 protein 
were expressed at low levels in either LSM12-depleted cells or LSM12-deleted cells compared with 
those in control cells (Figure III-2-15B, C, and D). To investigate how LSM12 up-regulates EPAC1 
expression, we generated EPAC1 reporter transgenes of which expression was transcriptionally driven 
by EPAC1 promoter or post-transcriptionally controlled by EPAC1 untranslated regions (UTRs) 
(Figure III-2-16A). While the loss of LSM12 function did not affect the EPAC1 promoter activity, we 
found that EPAC1 5’ UTR was necessary and sufficient for LSM12-dependent expression of the post-
transcriptional EPAC1 reporters (Figure III-2-16B, C). These results thus validate that LSM12 acts as 
a post-transcriptional activator of EPAC1.  
EPAC1 has been shown to act as a cAMP sensor for the activation of RAP signaling on the 
plasma membrane [181]. On the other hand, EPAC1 also localizes to the nuclear envelope and 
associates with nucleoporin complexes containing RAN, RANGAP1, RANBP2 (Ran-binding protein 
2, also known as NUP358), and importin β1 [181-183]. We thus hypothesized that the action of EPAC1 
in nucleoporin assembly or function might contribute to LSM12 effects on the RAN gradient and NCT. 
To test this possibility, we first examined if EPAC1 overexpression restored the RAN gradient in 
LSM12-deleted cells. Indeed, EPAC1 overexpression substantially suppressed the aberrant localization 
of RAN in the cytoplasm of LSM12-deleted cells, while negligibly affecting the RAN gradient in control 
cells (Figure III-2-17A, B). Consistent with this rescue effect, EPAC1 overexpression suppressed loss-
of-function effects of LSM12 on the disruption of NCT induced by poly(GR) overexpression (Figure 
III-2-17C, D). These data indicate that EPAC1 is limiting for sustaining the RAN gradient and NCT in 
LSM12-deleted cells. 
 Next, we asked whether the loss of EPAC1 function would be sufficient to induce cellular 
phenotypes observed with the loss of LSM12 function. To this end, we depleted endogenous EPAC1 
protein by transiently transfecting SH-SY5Y cells with siRNA targeting the EPAC1 transcript (Figure 
III-2-18A). EPAC1 depletion indeed decreased the ratio of nuclear to cytoplasmic RAN distribution 
regardless of poly(GR) overexpression (Figure III-2-18B), mimicking the RAN phenotypes in LSM12-
depleted or LSM12-deleted cells under basal conditions. Moreover, we observed non-additive 
disruption of the RAN gradient by EPAC1 depletion and LSM12 deletion, further confirming that 
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EPAC1 and LSM12 act in the same pathway for sustaining a RAN gradient. ISRIB treatment failed to 
suppress the effects of EPAC1 depletion on the RAN gradient (Figure III-2-18C, D) and poly(GR)-
induced disruption of NCT (Figure III-2-19), consistent with an SG-independent role of LSM12 on the 
RAN gradient and NCT. Not surprisingly, EPAC1 depletion enhanced nuclear accumulation of 
poly(GR) protein and increased the poly(GR)-expressing cell population harboring SGs (Figure III-2-
20). Consequently, nuclear membrane integrity was severely impaired by poly(GR) overexpression in 
EPAC1-depleted cells in an ISRIB-insensitive manner (Figure III-2-21). Finally, either heterozygosity 
of Epac deletion mutation [184] or RNA interference-mediated depletion of EPAC exacerbated 
degeneration of Drosophila photoreceptor neurons overexpressing poly(GR) protein (Figure III-2-22), 











Figure III-2-15. LSM12 post-transcriptionally up-regulates EPAC1 expression to sustain the RAN 
gradient for NCT.  
(A) Fold-changes in total transcript levels (x-axis) versus translating ribosome-associated transcript 
levels (y-axis) in LSM12-depleted cells were assessed by RNA sequencing (n = 2 biological replicates; 
n = 10,856 transcripts) and depicted as a scatter plot. (B) LSM12-depleted cells express low levels of 
EPAC1 transcript. Total RNA was prepared from controlshRNA and LSM12shRNA cells. The abundance of 
each transcript was quantified by real-time RT-PCR and normalized to that of GAPDH. Relative mRNA 
levels in LSM12shRNA cells were then calculated by normalizing to those in controlshRNA cells. Data 
represent means ± SEM (n = 3). *P < 0.05, ***P < 0.001, as determined by Student’s t-test. (C, D) 
LSM12-depleted and LSM12-deleted (LSM12KO) cells express low levels of EPAC1 protein. The 
abundance of each protein was quantified as in Figure III-2-1C. Data represent means ± SEM (n = 3). 




Figure III-2-16. LSM12 post-transcriptionally activates EPAC1 expression via the 5’ UTR. 
(A) A schematic representation of the EPAC1 locus and EPAC1 reporter constructs. Transcription of 
control and EPAC1 UTR (untranslated region) reporters was driven by heterologous cytomegalovirus 
(CMV) promoter. A promoter region in the EPAC1 locus (from -1805 to +71 in relative to the 
transcription start site +1) was subcloned upstream of the NLUC-coding sequence to measure the 
EPAC1 promoter activity by the NLUC activity. (B) LSM12 depletion post-transcriptionally decreases 
EPAC1 expression via the 5’ UTR. ControlshRNA and LSM12shRNA cells were co-transfected with each 
EPAC1 reporter and firefly luciferase (FLUC) expression vector (normalizing control). Luciferase 
reporter assays were performed 48 hours after transfection. NLUC activity was first normalized to 
FLUC activity per condition. Relative expression of each EPAC1 reporter in LSM12shRNA cells was then 
calculated by normalizing to the NLUC/FLUC value in controlshRNA cells. Data represent means ± SEM 
(n = 4). n.s., not significant; *P < 0.05, as determined by Student’s t-test. (C) LSM12 deletion post-
transcriptionally decreases EPAC1 expression via the 5’ UTR.. Data represent means ± SEM (n = 3). 




Figure III-2-17. EPAC1 overexpression restores the nucleocytoplasmic RAN gradient in LSM12-
deleted cells.  
(A) Control and LSM12KO cells were transfected with an expression vector for FLAG or FLAG-tagged 
EPAC1 and then co-stained with anti-RAN antibody (red), anti-FLAG antibody (green), and Hoechst 
33258 (blue) 48 hours after transfection. (B) The nucleocytoplasmic RAN gradient was quantified as 
in Figure III-2-7. Data represent means ± SEM (n = 103–107 cells from 3 independent experiments). 
n.s., not significant; ***P < 0.001, as determined by two-way ANOVA with Tukey’s post hoc test. (C) 
EPAC1 overexpression suppresses LSM12-deletion effects on the poly(GR)-induced disruption of NCT. 
Control and LSM12KO cells were co-transfected with different combinations of expression vectors for 
S-tdT, GFP-GR100, and FLAG-tagged EPAC1, and then co-stained with anti-FLAG antibody (magenta) 
and Hoechst 33258 (blue) 48 hours after transfection. (D) NCT of S-tdT reporter proteins was quantified 
as in Figure III-2-6. Two-way ANOVA detected significant interaction effects of GFP-GR100 and 
LSM12 deletion on NCT only in FLAG-expressing cells (P = 0.0018). Data represent means ± SEM 
(n = 123–153 cells from 3 independent experiments). n.s., not significant; ***P < 0.001, as determined 




Figure III-2-18. EPAC1 depletion is sufficient to phenocopy loss of LSM12 function in poly(GR) 
toxicity.  
(A) SH-SY5Y cells were transfected with control or two independent EPAC1 siRNAs. Total cell 
extracts were prepared 72 hours after transfection and immunoblotted with anti-EPAC1 or anti-tubulin 
(loading control) antibodies. (B) LSM12 deletion and EPAC1 depletion non-additively disrupt the RAN 
gradient. The nucleocytoplasmic RAN gradient was quantified as in Figure III-2-7. Data represent 
means ± SEM (n = 62–67 cells from 3 independent experiments). n.s., not significant; ***P < 0.001, as 
determined by two-way ANOVA with Tukey’s post hoc test. (C) SH-SY5Y cells were transfected with 
controlsiRNA or EPAC1siRNA 24 hours before transfecting with an expression vector for GFP or GFP-
GR100. Transfected cells were co-stained with anti-RAN antibody (red), anti-G3BP1 antibody (magenta), 
and Hoechst 33258 (blue) 72 hours after siRNA transfection. Where indicated, cells were treated with 
2 µM ISRIB or DMSO (vehicle control) for 5 hours before antibody staining. (D) The 
nucleocytoplasmic RAN gradient was quantified as in Figure III-2-7. Data represent means ± SEM 
(n = 124–145 GFP– or GFP-GR100–positive cells from 3 independent experiments). n.s., not significant; 





Figure III-2-19. EPAC1 depletion exacerbates the poly(GR)-induced disruption of NCT in an 
ISRIB-insensitive manner.  
(A) SH-SY5Y cells were co-transfected with siRNA and expression vectors for S-tdT and GFP-GR100. 
Where indicated, transfected cells were incubated with 2 µM ISRIB or DMSO (vehicle control) for 
5 hours before co-staining with anti-G3BP1 antibody (magenta) and Hoechst 33258 (blue) at 48 hours 
after plasmid DNA transfection. (B) NCT of S-tdT reporter proteins was quantified as in Figure III-2-
6. Two-way ANOVA detected significant interaction effects of GFP-GR100 and ISRIB treatment on 
NCT in controlsiRNA cells (P = 0.0097), but not in EPAC1siRNA cells (P = 0.5310 for EPAC1siRNA #1; P 
= 0.5218 for EPAC1siRNA #2); significant interaction effects of GFP-GR100 and EPAC1 depletion on 
NCT regardless of ISRIB treatment (P = 0.0194 for EPAC1siRNA #1 in DMSO; P = 0.0133 for 
EPAC1siRNA #2 in DMSO; P < 0.0001 for both EPAC1siRNA in ISRIB). Data represent means ± SEM (n 






Figure III-2-20. EPAC1 depletion facilitates the nuclear accumulation of poly(GR) proteins but 
suppresses the maturation of poly(GR)-induced SGs.  
(A) SH-SY5Y cells were co-transfected with each siRNA and a GFP-GR100 expression vector as above. 
Transfected cells were co-stained with anti-G3BP1 antibody (red) and Hoechst 33258 (blue) at the 
indicated time-points after plasmid DNA transfection. (B) The assemblies of poly(GR)-induced SGs 
and nuclear poly(GR) granules were quantified as in Figure III-2-1. Data represent means ± SEM (n = 
10–19 confocal images obtained from 3 independent experiments; n = 239–413 GFP-GR100–positive 











Figure III-2-21. EPAC1 depletion exacerbates the poly(GR)-induced disruption of the nuclear 
lamina. 
(A) SH-SY5Y cells were co-transfected with each siRNA and a GFP-GR100 expression vector, treated 
with 2 µM ISRIB or DMSO (vehicle control), and then co-stained with anti-lamin B1 antibody (red), 
anti-G3BP1 antibody (magenta), and Hoechst 33258 (blue) as described above. Yellow arrows indicate 
GFP-GR100–positive cells with severe nuclear lamina disruption. (B) The abnormal nuclear laminar 
morphology was quantified as in Figure III-2-10. Two-way ANOVA detected significant interaction 
effects of GFP-GR100 and EPAC1 depletion on the nuclear integrity regardless of ISRIB treatment (P < 
0.0001 for both DMSO and ISRIB). Data represent means ± SEM (n = 15 confocal images obtained 
from 3 independent experiments; n = 313–545 GFP– or GFP-GR100–positive cells). n.s., not significant; 





Figure III-2-22. Poly(GR)-induced neurodegeneration is exacerbated in Drosophila Epac mutants.  
(A) Loss of Epac function exacerbates the neurodegenerative effects of C9ORF72-derived poly(GR) 
proteins in a Drosophila eye model. Transgenic GR36 protein was overexpressed in photoreceptor 
neurons (GMR>GR36) of wild-type (control), heterozygous Epac-deletion mutant (EpacD), or EPAC-
depleted flies (EpacRNAi #1, v50372; EpacRNAi #2, v110077). Representative images of one-week-old 
male flies per genotype are shown for ommatidial disorganization and necrotic spots. GMR served as 
transgenic controls. (B) The eye phenotypes were scored in individual transgenic flies (n = 123–170; 
weak, moderate, strong), and their relative distribution was calculated for each genotype. ***P < 0.001, 
as determined by chi-square test. (C) Two Epac RNAi transgenes (EpacRNAi #1, v50372; EpacRNAi #2, 
v110077) were individually overexpressed in the Drosophila photoreceptor neurons by GMR-GAL4 
driver. Total RNA was prepared from fly heads. The abundance of Epac transcripts was quantified by 
real-time RT-PCR and normalized to that of poly(A)-binding protein. Relative Epac mRNA levels were 
then calculated by normalizing to those in GMR-GAL4/+ heterozygous controls. Data represent means 




III-2-6. Overexpression of LSM12 or EPAC1 rescues NCT-relevant pathologies in ALS 
patient-derived neurons 
Our genetic analyses of the loss-of-function phenotypes indicate that deficits in the LSM12-EPAC1 
pathway disrupt the RAN gradient, making the affected cells more susceptible to genetic or 
environmental perturbations in NCT-related physiology. Nonetheless, we reasoned that a 
neuroprotective function of this pathway would be better demonstrated if its upregulation could rescue 
ALS/FTD-relevant pathologies in the RAN gradient and NCT. We first tested this possibility in SH-
SY5Y cells transiently expressing poly(GR) protein. Indeed, overexpression of LSM12 or EPAC1 
significantly suppressed poly(GR)-induced disruption of the RAN gradient (Figure III-2-23A, B) and 
nuclear integrity (Figure III-2-23C, D).  
 To validate the disease relevance of these findings, we employed induced pluripotent stem cell 
(iPSC)-derived neurons from three C9ORF72-associated ALS patients (C9-ALS iPSNs). A previous 
study showed that all these C9-ALS iPSC lines (CS28, CS29, and CS52) had mutant C9ORF72 alleles 
with ~800 hexanucleotide repeats [185]. In addition, an isogenic control iPSC line (CS29-ISO) was 
established by the CRISPR/Cas9-mediated deletion of the hexanucleotide repeat expansion in one of 
these C9-ALS iPSC lines (C9-ALS CS29) [186]. This isogenic pair (CS29-ISO and C9-ALS CS29) 
accordingly served as a good resource to compare any effects of the C9ORF72 hexanucleotide repeats 
and our lentiviral transgenes in the same genetic background. Immunofluorescence analyses confirmed 
comparable neuronal differentiation from CS29-ISO and C9-ALS CS29 iPSC lines (Figure III-2-24A). 
Our experimental conditions led to mixed neuronal cultures, including ~95% MAP2-positive (a 
neuronal marker), 70% ChAT-positive (cholinergic neurons), and 25-30% HB9-positive cells (motor 
neurons), as reported previously [140]. Moreover, iPSNs from C9-ALS CS29, but not their isogenic 
control iPSNs, displayed poly(GR) aggregates at readily detectable levels (Figure III-2-24B). 
We further found that the abundance of LSM12 and EPAC1 proteins was significantly 
decreased in C9-ALS iPSNs from all three patients, compared to control iPSNs (Figure III-2-25A). 
Quantitative transcript analyses revealed lower levels of LSM12 and EPAC1 mRNAs in C9-ALS iPSNs 
(Figure III-2-25B). While the underlying mechanism remains to be determined, we hypothesized that 
this down-regulation of the LSM12-EPAC1 pathway might be limiting for NCT-relevant pathologies in 
C9-ALS iPSNs [118, 120, 126, 140]. A significant reduction (~35%) in the nuclear to cytoplasmic ratio 
of RAN protein in C9-ALS iPSNs was partially, but significantly, rescued by lentiviral overexpression 
of LSM12 or EPAC1 (Figure III-2-26). We confirmed that their overexpression negligibly affected 
neuronal differentiation efficiency per se (Figure III-2-27). TDP-43 pathogenesis is the most prominent 
feature in ALS/FTD, and it has been shown that the loss of nuclear function, as well as the gain of 
cytoplasmic function, contribute to the underlying neurodegenerative processes [123-125, 175, 187-
189]. Given that the nuclear import of TDP-43 is RAN dependent [123, 124], we further assessed the 
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neuroprotective effects of the LSM12-EPAC1 pathway on the cytoplasmic mislocalization of TDP-43 
in C9-ALS iPSNs [118]. Consistent with the RAN gradient rescue, overexpression of LSM12 or EPAC1 
suppressed TDP-43 mislocalization to the cytoplasm of C9-ALS iPSNs (Figure III-2-28). On either 
the RAN gradient or TDP-43 mislocalization, LSM12V135I overexpression exhibited dominant-negative 
effects in control iPSNs (Figure III-2-27, III-2-28).  
Finally, we asked whether the transgenic enhancement of the LSM12-EPAC1 pathway could 
alleviate neurodegenerative phenotypes in C9-ALS iPSNs. Consistent with previous observations [190, 
191], the percentages of neurons expressing cleaved caspase-3 were substantially elevated in C9-ALS 
iPSNs from all three patients (Figure III-2-29), likely indicating their pathogenic activation of the 
proapoptotic pathway. We further found that overexpression of LSM12 or EPAC1 partially, but 
significantly, suppressed the caspase-3 activation for apoptosis in all three C9-ALS iPSN lines. Taken 
together, these lines of evidence convincingly support our conclusion that LSM12 and EPAC1 
constitute a neuroprotective pathway for sustaining the RAN gradient and NCT in the pathophysiology 










Figure III-2-23. EPAC1 suppresses poly(GR) toxicity relevant to NCT and nuclear integrity. 
(A, B) Overexpression of LSM12 or EPAC1 suppresses the poly(GR)-induced disruption of the RAN 
gradient. SH-SY5Y cells were co-transfected with different combinations of expression vectors for 
FLAG-tagged LSM12, FLAG-tagged EPAC1, and GFP-GR100. Transfected cells were co-stained with 
anti-RAN antibody (red), anti-FLAG antibody (magenta), and Hoechst 33258 (blue). The 
nucleocytoplasmic RAN gradient was quantified as in Figure III-2-7. Two-way ANOVA detected 
significant interaction effects of GFP-GR100 with LSM12 or EPAC1 overexpression on the RAN 
gradient (P < 0.0001 for both). Data represent means ± SEM (n = 101–109 GFP– or GFP-GR100–
positive cells from 3 independent experiments). n.s., not significant; ***P < 0.001, as determined by 
Tukey’s post hoc test. (C, D) Overexpression of LSM12 or EPAC1 suppresses the poly(GR)-induced 
disruption of the nuclear lamina. Yellow arrows indicate GFP-GR100–positive cells with severe nuclear 
lamina disruption. Magenta arrows indicate cells overexpressing LSM12-FLAG or EPAC1-FLAG 
protein. The abnormal morphology of the nuclear lamina was quantified as in Figure III-2-10. Data 
represent means ± SEM (n = 11–19 confocal images obtained from 3 independent experiments; n = 
235–508 GFP– or GFP-GR100–positive cells). n.s., not significant; *P < 0.05, ***P < 0.001, as 





Figure III-2-24. C9-ALS iPSCs and their isogenic control cells exhibit comparable efficiency of 
motor neuron differentiation.  
(A) C9-ALS iPSNs (CS29) and isogenic control iPSNs (CS29-ISO) were fixed 7 days (1-week-old) or 
21 days (3-week-old) after neuronal differentiation from their parental NPCs. Immunofluorescence 
assays were performed using anti-ChAT antibody (red), anti-MAP2 antibody (green), anti-HB9 
antibody (magenta), and Hoechst 33258 (blue). The percentages of MAP2-positive (a neuronal marker), 
ChAT-positive (cholinergic neurons), and HB9-positive cells (motor neurons) were calculated and 
averaged (n = 7 confocal images from 3 independent experiments; n = 511–624 Hoechst–positive cells). 
Error bars indicate SEM. n.s., not significant; as determined by two-way ANOVA with Tukey’s post 
hoc test. (B) poly(GR) aggregates are readily detectable in C9-ALS iPSNs, but not isogenic control 
neurons. iPSNs were co-stained with anti-MAP2 antibody (green), anti-poly(GR) antibody (red), and 





Figure III-2-25. LSM12 and EPAC1 expression is reduced in C9-ALS iPSNs. 
(A) C9-ALS iPSNs (CS28, CS29, and CS52) and control iPSNs (CS0, CS29-ISO, CS4) were harvested 
21 days after neuronal differentiation from neural progenitor cells (NPCs). Total cell extracts from 3-
week-old iPSNs were resolved by SDS-PAGE and immunoblotted with anti-LSM12, anti-EPAC1, and 
anti-tubulin (loading control) antibodies. The abundance of each protein was quantified as in Figure 
III-2-1C. Error bars indicate SEM (n = 3 independent differentiation experiments). *P < 0.05, 
**P < 0.01, as determined by one-way ANOVA with Dunnett’s post hoc test. (B) C9-ALS iPSNs 
express low levels of LSM12 and EPAC1 transcripts. Total RNA was prepared from 3-week-old iPSNs, 
and the abundance of each transcript was quantified as in Figure III-2-15B. Data represent means ± 
SEM (n = 3 independent differentiation experiments). n.s., not significant; *P < 0.05, as determined by 






Figure III-2-26. Overexpression of LSM12 or EPAC1 rescues the RAN gradient in C9-ALS iPSNs.  
(A) NPCs from C9-ALS iPSCs (CS29) and their isogenic control cells (CS29-ISO) were transduced 
with individual recombinant lentiviruses that express the indicated FLAG-tagged proteins along with a 
GFP reporter. iPSNs were fixed 21 days after neuronal differentiation from NPCs and co-stained with 
anti-RAN antibody (red), anti-MAP2 antibody (magenta), and Hoechst 33258 (blue). (B) The 
nucleocytoplasmic RAN gradient was quantified as in Figure III-2-7. Two-way ANOVA detected 
significant interaction effects of C9-ALS and lentiviral overexpression on the RAN gradient (P = 0.0051 
for LSM12; P = 0.0066 for LSM12V135I; P = 0.0041 for EPAC1). Data represent means ± SEM 
(n = 100–105 GFP–positive cells from 4 independent differentiation experiments). n.s., not significant; 










Figure III-2-27. Lentiviral overexpression of LSM12 or EPAC1 negligibly affects the efficiency of 
neuronal differentiation from neural progenitor cells.  
(A) SH-SY5Y cells were infected with individual recombinant lentiviruses that express the indicated 
FLAG-tagged proteins along with a GFP reporter. Total cell extracts were prepared 48 hours after 
infection and immunoblotted with anti-FLAG, anti-GFP, and anti-tubulin (loading control) antibodies. 
(B) NPCs from C9-ALS iPSCs (CS29) and their isogenic control cells (CS29-ISO) were transduced 
with the indicated recombinant lentiviruses. Three-week-old iPSNs were fixed and co-stained with anti-
MAP2 antibody (magenta) and Hoechst 33258 (blue). (C) The percentages of MAP2–positive neurons 
among GFP–positive cells were calculated and averaged (n = 8 confocal images obtained from 4 
independent experiments; n = 123–156 GFP–positive cells). Error bars indicate SEM. n.s., not 










Figure III-2-28. Overexpression of LSM12 or EPAC1 suppresses the pathogenic mislocalization 
of TDP-43 in the cytoplasm of C9-ALS iPSNs. 
(A) Three-week-old iPSNs (CS29-ISO and C9-ALS CS29) were co-stained with anti-TDP-43 antibody 
(red), anti-MAP2 antibody (magenta), and Hoechst 33258 (blue). (B) The relative distribution of 
endogenous TDP-43 proteins was quantified as in Figure III-2-7. Two-way ANOVA detected 
significant interaction effects of C9-ALS and lentiviral overexpression on the RAN gradient (P = 0.0154 
for LSM12; P = 0.0120 for EPAC1). Data represent means ± SEM (n = 102–104 GFP–positive cells 
from 4 independent differentiation experiments). n.s., not significant; *P < 0.05, **P < 0.01, 







Figure III-2-29. Lentiviral overexpression of LSM12 or EPAC1 suppresses caspase-3 activation 
in C9-ALS iPSNs.  
(A) Three-week-old iPSNs (CS29-ISO and C9-ALS CS29) were co-stained with anti-cleaved caspase-
3 antibody (red), anti-MAP2 antibody, and Hoechst 33258 (blue). (B) The relative percentages of iPSNs 
expressing cleaved caspase-3 were averaged from 15 confocal images of random fields of interest per 
condition (n = 771–1129 GFP-positive cells from 3 independent differentiation experiments). Data 
represent means ± SEM. n.s., not significant; ***P < 0.001, as determined by two-way ANOVA with 
Tukey’s post hoc test. (C) Three-week-old C9-ALS iPSNs (CS28 and CS52) and control iPSNs (CS0 
and CS4) were fixed and co-stained with anti-cleaved caspase-3 antibody, anti-MAP2 antibody, and 
Hoechst 33258. Data represent means ± SEM (n = 828–1122 GFP-positive cells from 3 independent 
differentiation experiments). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined 
by two-way ANOVA with Tukey’s post hoc test. 
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III-2-7. The LSM12-EPAC1 pathway promotes RAN-Importin β1 loading onto RANBP2-
RANGAP1 at the nuclear pore complex 
Previous studies have suggested that RANBP2-RANGAP1 recruits the RAN-importin β1 complex to 
the cytoplasmic side of the nuclear pore complex, facilitating its recycling across the nuclear membrane 
[192, 193]. RAN-GTP actually promotes the association of importin β1 with RANBP2, whereas RAN-
GDP loses its affinity for both proteins [192, 194, 195]. Moreover, EPAC1 associates preferentially 
with RAN-GTP, and EPAC1 overexpression stabilizes the association between RAN and RANBP2 
[181]. We thus hypothesized that the LSM12-EPAC1 pathway might control the dynamic assembly of 
the RAN-associating protein complex, thereby contributing to the establishment of the 
nucleocytoplasmic RAN gradient. To examine this possibility, we performed a series of 
immunoprecipitation (IP) experiments and compared the biochemical composition of RAN-containing 
protein complexes in different genetic settings and pharmacological conditions.  
As expected, an anti-RANBP2 antibody co-purified RAN, importin β1, and SUMOylated 
RANGAP1, together with RANBP2, from control cell extracts (Figure III-2-30A). LSM12 deletion 
enhanced the association of SUMOylated RANGAP1 with RANBP2 while dissociating RAN and 
importin β1 from the RANBP2-RANGAP1 complex. Similar results were obtained by reciprocal IP 
using an anti-RANGAP1 antibody (Figure III-2-30B). Pre-treatment with a cell-permeable cAMP 
analog (8-pCPT-2-O-Me-cAMP-AM/007-AM) neither affected the assembly of wild-type RAN-
associating protein complex nor rescued LSM12-deletion phenotypes (Figure III-2-31). EPAC1 
activation by cAMP thus is unlikely involved in these biochemical interactions. Similar IP experiments 
in EPAC1-depleted cells further revealed that EPAC1 depletion caused dissociation of RAN and 
importin β1 from the RANBP2-RANGAP1 complex (Figure III-2-32), consistent with LSM12-deletion 
effects.  
In either case, the enrichment of endogenous EPAC1 protein in RANBP2-RANGAP1 
immunoprecipitates was not readily detectable, possibly owing to the abundance of free EPAC1 
proteins in the cytoplasm compared with those associated with the RANBP2-RANGAP1 complex at 
the nuclear pore. Affinity purification of FLAG-tagged EPAC1 protein indeed confirmed its association 
with RANGAP1, RANBP2, importin β1, and RAN (Figure III-2-33). Moreover, overexpression of the 
FLAG-tagged EPAC1 protein restored the assembly of RAN-associating protein complexes in LSM12-
deleted cells, consistent with its rescue effects on the RAN gradient and NCT. These results indicate 
that the LSM12-EPAC1 pathway promotes the association of RAN and importin β1 with the RANBP2-
RANGAP1 complex. Stronger interactions between RANBP2 and RANGAP1 in LSM12-deleted or 





Figure III-2-30. LSM12 deletion dissociates RAN and importin β1 from the RANBP2-RANGAP1 
complex.  
(A, B) Soluble extracts from control and LSM12KO cells were immunoprecipitated with anti-RANBP2 
(A) or anti-RANGAP1 antibodies (B). Purified immunoprecipitation (IP) complexes were resolved by 
SDS-PAGE and immunoblotted with specific antibodies (left). Asterisks indicate SUMOylated 












Figure III-2-31. A selective activator of EPAC1 does not rescue the association of RAN and 
importin β1 with the RANBP2-RANGAP1 complex in LSM12-deleted cells.  
Pre-treatment with a cell-permeable cAMP analog (8-pCPT-2-O-Me-cAMP-AM/007-AM) neither 
affected the assembly of wild-type RAN-associating protein complex nor rescued LSM12-deletion 
phenotypes Where indicated, cells were pre-incubated with 1 µM 007-AM or DMSO (vehicle control) 
at 37°C for 1 hour before immunoprecipitating soluble cell extracts with control IgG or anti-RANBP2 










Figure III-2-32. EPAC1 depletion dissociates RAN and importin β1 from the RANBP2-
RANGAP1 complex.  
Soluble extracts from control or EPAC1 siRNA-transfected cells were immunoprecipitated with anti-
RANBP2 (A) or anti-RANGAP1 antibodies (B). Asterisks indicate SUMOylated RANGAP1. Input, 




Figure III-2-33. EPAC1 overexpression restores the assembly of RAN-associating nuclear pore 
complex in LSM12-deleted cells. 
Control and LSM12KO cells were transfected with FLAG or EPAC1-FLAG expression vector. Soluble 
extracts were prepared 48 hours after transfection and then immunoprecipitated with anti-FLAG 
antibody. Asterisks indicate SUMOylated RANGAP1. Input, 4.5% of soluble extracts used in each IP. 
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III-2-8. RAN overexpression mitigates EPAC1-depletion effects on poly(GR) toxicity 
To determine whether the status of RAN-bound GTP hydrolysis contributes to EPAC1 effects on the 
assembly of RAN-associating protein complexes, we added a hydrolysis-resistant GTP analog (GTPγS) 
to cell extracts before IP. The assembly of the RANBP2-associating protein complex was insensitive to 
GTPγS in control cells (Figure III-2-34). By contrast, pre-incubation of GTPγS with extracts from 
EPAC1-depleted cells restored the association of RAN and importin β1 with the RANBP2-RANGAP1 
complex to control cell levels (Figure III-2-34). These results indicate that RAN-GTP is specifically 
limiting for the stable association of RAN-importin β1 with RANBP2-RANGAP1 in EPAC1-depleted 
cells. Given that the intracellular concentration of GTP is ~10-fold higher than that of GDP, we 
hypothesized that overexpression of wild-type RAN proteins would supply extra RAN-GTP in EPAC1-
depleted cells, and thereby rescue cellular phenotypes relevant to the lack of RAN-GTP. We indeed 
found that RAN overexpression substantially suppressed the formation of nuclear GR granules (Figure 
III-2-35) and poly(GR)-induced disruption of the nuclear membrane in EPAC1-depleted cells (Figure 
III-2-36), while modestly inhibiting poly(GR) effects in control cells. RAN overexpression also 
suppressed EPAC1-depletion effects on poly(GR)-induced disruption of NCT, although it had 
negligible effects in control cells (Figure III-2-37). Taken together, these data demonstrate that the 
LSM12-EPAC1 pathway facilitates the nucleocytoplasmic recycling of RAN-GTP, and thereby confers 












Figure III-2-34. The hydrolysis-resistant GTP analog, GTPγS, blocks the dissociation of RAN and 
importin β1 from the RANBP2-RANGAP1 complex in EPAC1-depleted cells.  
Where indicated, soluble cell extracts were pre-incubated with 0.1 mM GTPγS or DMSO (vehicle 
control) at 25°C for 30 minutes before immunoprecipitating soluble cell extracts with control IgG or 
anti-RANBP2 antibody. Asterisks indicate SUMOylated RANGAP1. Input, 4.5% of soluble extracts 












Figure III-2-35. RAN overexpression suppresses the nuclear assembly of poly(GR) granules.  
SH-SY5Y cells were co-transfected with siRNA, GFP-GR100, and RAN-FLAG expression vectors, as 
in Figure III-2-18C. Transfected cells were co-stained with anti-lamin B1 antibody (red), anti-FLAG 
antibody (magenta), and Hoechst 33258 (blue) 48 hours after plasmid DNA transfection. The assembly 
of nuclear poly(GR) granules was quantified similarly as in Figure III-2-1. Data represent means ± 
SEM (n = 15–17 confocal images obtained from 3 independent experiments; n = 280–471 GFP-GR100–
positive cells). n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001, as determined by two-way 














Figure III-2-36. RAN overexpression suppresses the poly(GR)-induced disruption of the nuclear 
lamina.  
(A) SH-SY5Y cells were co-transfected with siRNA, GFP-GR100, and RAN-FLAG expression vectors, 
as in Figure III-2-18C. Yellow arrows indicate GFP-GR100–positive cells with severe nuclear lamina 
disruption. Magenta arrows indicate cells overexpressing RAN-FLAG protein. (B) The abnormal 
morphology of the nuclear lamina was quantified as in Figure III-2-10. Data represent means ± SEM 
(n = 16–17 confocal images obtained from 3 independent experiments; n = 325–547 GFP– or GFP-
GR100–positive cells). n.s., not significant; **P < 0.01, ***P < 0.001, as determined by two-way 












Figure III-2-37. RAN overexpression suppresses the effects of EPAC1 depletion on the poly(GR)-
induced disruption of NCT.  
(A) SH-SY5Y cells were co-transfected with siRNA and expression vectors for S-tdT, GFP-GR100, and 
RAN-FLAG, as in Figure III-2-18C. Transfected cells were co-stained with anti-FLAG antibody 
(magenta) and Hoechst 33258 (blue) 48 hours after plasmid DNA transfection. (B) NCT of S-tdT 
reporter proteins was quantified as in Figure III-2-6. Two-way ANOVA detected significant 
interaction effects of GFP-GR100 and EPAC1 depletion on NCT only in FLAG-expressing cells (P = 
0.0005 for EPAC1siRNA #1; P = 0.0093 for EPAC1siRNA #2). Data represent means ± SEM (n = 113–115 
GFP– or GFP-GR100–positive cells from 3 independent experiments). n.s., not significant; *P < 0.05, 





Figure III-2-38. A model for the LSM12-EPAC1 pathway that establishes the nucleocytoplasmic 
RAN gradient and suppresses the toxicity of C9ORF72-derived poly(GR) protein.  
The LSM12-EPAC1 pathway contributes to the assembly of the RAN-associating protein complex at 
the cytoplasmic side of the nuclear pore, thereby facilitating RAN-GTP recycling. The loss-of-function 
of the LSM12-EPAC1 pathway dissociates RAN and importin β1 from the RANBP2-RANGAP1 
complex and delays the nuclear entry of RAN for recycling. Disruption of the RAN gradient impairs 
NCT, promotes the nuclear assembly of poly(GR) granules, and increases poly(GR) toxicity (e.g., loss 
of nuclear laminar integrity, degeneration of Drosophila photoreceptor neurons). Asterisks indicate 


































Part 1. LSM12 and ME31B/DDX6 define distinct modes of post-transcriptional regulation 
by ATAXIN-2 protein complex in Drosophila circadian pacemaker neurons 
Post-transcriptional regulation is emerging as an important clock mechanism that supports robust 
circadian gene expression even in the absence of rhythmic transcription [44]. Identification of the post-
transcriptional co-activator complex of ATX2-TYF has been one of the strongest evidence that 
pacemaker neuron-specific, translational control of a core clock gene plays a pivotal role in sustaining 
circadian rhythms [45, 46, 152]. These studies were also identified ATX2 as a post-transcriptional co-
activator for a specific RNA-binding protein. Here we demonstrate that two ATX2-associating factors 
govern circadian periods and rhythmicity, respectively, by switching the ATX2 complex into distinct 
modes of post-transcriptional regulation (Figure III-1-17). 
Lsm12 was initially identified by yeast two-hybrid screening as an interaction partner of a yeast 
homolog of Atx2 [196]. Later, their biochemical association was confirmed by analyses in translating 
ribosomal complexes in yeast [154]. Nevertheless, the functional significance of LSM12 has been 
largely unknown. The functional characterization of Lsm12-deficient animal models clearly 
demonstrated that LSM12 has a novel clock function as a TYF-specific molecular adaptor in the ATX2 
complex. The TYF-dependent translation of PER is thus key to the 24-hour periodicity sustained by the 
ATX2-LSM12-TYF pathway. Considering that TYF is an insect-specific RBP that associates with per 
mRNAs independently of the ATX2 complex [46], our data support the idea that ATX2 and LSM12 
homologs may have co-evolved to retain the ATX2-LSM12 interaction across eukaryotic species. We 
reason that other RBPs may analogously recruit the ATX2 co-activator complex via LSM12 to activate 
the translation of their own target mRNAs. These findings far advance our understanding of the 
generalizable modes of action for the ATX2 co-activator, and establish a principal mechanism for 
ATX2-dependent post-transcriptional regulation.  
We further defined novel clock function of me31B and Not1 using transgenic RNAi animals. 
Their phenotypic homology (i.e., poor behavioral rhythmicity with loss of the PDF rhythms) and genetic 
interaction with Atx2 on the rhythm amplitude suggest that the ATX2-ME31B-NOT1 pathway acts in 
the clock output, functionally distinguishable from the ATX2-LSM12-TYF pathway. Compared to the 
molecular mechanisms underlying the rhythmic expression of circadian clock genes, how the molecular 
clocks in the circadian pacemaker neurons generate the rhythmic output (e.g., PDF rhythms and 
circadian locomotor behaviors) is still poorly understood. It is thus challenging to pinpoint a rate-
limiting gene for the circadian rhythmicity sustained by the ATX2-ME31B-NOT1 pathway. 
Nonetheless, our data strengthen the significance of the previously reported, biochemical interaction 
between ME31B/DDX6 and NOT1 in a physiologically-relevant context [167-169]. Moreover, we 
discovered that ATX2 supports NOT1-dependent gene silencing and that ME31B specifically promotes 
the assembly of ATX2-NOT1 complex.  
116 
These findings elucidate that the ATX2 complex is geared towards a post-transcriptional 
repressor by its associating factors ME31B and NOT1. In addition, stronger effects of Atx2 and me31B 
on the deadenylation-independent translational repression by NOT1 predict that the substrate specificity 
of the ATX2-ME31B-NOT1 pathway might be conferred by short polyA-tail length in mRNAs, 
possibly including those involved in the clock output process. Given the implication of the CCR4-NOT 
complex in miRNA-dependent post-transcriptional regulation, our results explain Atx2 effects on the 
miRNA-mediated gene silencing [67]. It is thus possible that generic deficits in the miRNA pathways 
collectively form the basis for the compromised rhythmicity seen in RNAi flies relevant to the ATX2-
ME31B-NOT1 complex. This notion is consistent with the previous observations that dysfunction in 
the miRNA pathway impairs the rhythm amplitude in circadian behaviors [197, 198].  
Taken together, we demonstrate that specific ATX2-associating factors set the distinct modes 
of post-transcriptional regulation mediated by the ATX2 protein complex. Given the evolutionary 
conservation of the modular architecture in the ATX2 complex, we propose that RBP-specific 
engagement of the ATX2-LSM12 complex and substrate-specific post-transcriptional effects of the 
ATX2-ME31B-NOT1 complex may constitute two fundamental mechanisms in ATX2-dependent gene 
expression. It will be particularly interesting to determine if these ATX2-associating factors play similar 




Part 2. LSM12-EPAC1 defines a neuroprotective pathway that sustains the 
nucleocytoplasmic RAN gradient 
Identification of non-canonical translation products from hexanucleotide repeat expansions in the 
C9ORF72 locus and their impact on specific aspects of cell physiology have advanced our 
understanding of the pathogenesis of ALS/FTD [95, 96]. C9ORF72-derived poly(GR) proteins 
assemble into distinct intracellular compartments, yet they also induce the formation of SGs [199]. Non-
functional sequestration of NCT-related factors into SGs has been proposed as a key mechanism for the 
NCT deficits implicated in ALS/FTD [126]. This has been validated by modifier screens in yeast and 
Drosophila genetic models [118, 120, 200], indicating strong conservation of their pathogenic 
mechanism. Mutations in ATXN2, one of these genetic modifiers, are indeed associated with ALS [59], 
and it has been shown that ATXN2 facilitates neurodegeneration, in part, by promoting SG formation 
[65, 126]. As expected, we found that ATXN2 and ATXN2-associated LSM12 make a non-additive 
contribution to the dynamic assembly of SGs. Unexpectedly, however, we discovered opposing effects 
of LSM12 and its post-transcriptional downstream effector, EPAC1, on neurodegeneration. The LSM12-
EPAC1 pathway assembles the RAN-associating nuclear pore complex and establishes the 
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nucleocytoplasmic RAN gradient, thereby antagonizing the effects of poly(GR) protein on NCT and 
nuclear membrane integrity. Our definition of the neuroprotective LSM12-EPAC1 pathway was further 
supported by its suppression of NCT-relevant pathologies and caspase-3 activation for apoptosis in C9-
ALS iPSNs. 
We propose that EPAC1 mediates the immediate recycling of nuclear RAN-GTP by 
supporting the stable association of RAN-importin β1 with RANBP2-RANGAP1 at the cytoplasmic 
side of the nuclear pore complex (Figure III-2-38). An EPAC1 deficiency, on the other hand, would 
allow nuclear RAN-GTP to diffuse out of the nuclear pore and further localize in the cytoplasm. The 
cytoplasmic RANGAP complex (e.g., RANBP1-RANGAP) then mediates RAN-GTP hydrolysis [201], 
thereby delaying the nuclear import of RAN-GDP by NTF2 (nuclear transport factor 2) [202-204] and 
limiting the regeneration of RAN-GTP from RAN-GDP by nuclear RCC1/RANGEF. RAN 
overexpression may increase the total flux of RAN recycling and elevate the local concentration of 
RAN at the nuclear pore complex. Consequently, RAN overexpression could facilitate NTF2-dependent 
nuclear import of RAN-GDP in EPAC1-depleted cells, partially restore nucleocytoplasmic RAN 
gradient, and compensate for the loss of EPAC1 function in the assembly of RAN-associating protein 
complexes at the nuclear pore. This model may explain our observation that RAN overexpression 
rescues EPAC1-depletion phenotypes in NCT and poly(GR) toxicity. Notably, RAN overexpression 
similarly suppresses the cytotoxic effects of mutant huntingtin through a mechanism that also involves 
disruption of the RAN gradient and NCT [115].  
When transiently expressed in cell culture, poly(GR) proteins display heterogeneity in their 
subcellular expression patterns, ranging from a uniform distribution in the cytoplasm to nucleolar 
localization [98, 100, 126]. We found that cytoplasmic poly(GR) protein accumulated gradually in sub-
nuclear compartments, a localization pattern that strongly correlated with the loss of nuclear integrity, 
as assessed by invaginations of the nuclear lamina. Given the active role of RAN in nucleating formation 
of the nuclear envelope [205, 206] and assembly of the nuclear pore complex [207, 208], we speculate 
that poly(GR)-induced disruption of the RAN gradient feeds forward to increase the permeability of the 
nuclear envelope, allowing more cytoplasmic poly(GR) protein to enter the nucleus and trigger nuclear 
pathogenesis, including nucleolar stress [98-101]. Consistent with this idea, we showed that RAN 
overexpression was sufficient to suppress the nuclear translocation of cytoplasmic poly(GR) proteins 
and sustain nuclear integrity in poly(GR)-expressing cells. This aspect of RAN function is relevant to 
the chromatin association of RAN and RCC1/RANGEF, which intrinsically cues the relative location 
of nuclei and generates the RAN-GTP gradient during mitosis [209, 210]. Nonetheless, it remains to be 
determined if poly(GR)-induced disruption of the RAN gradient comparably affects the functionality 
of the nuclear envelope in post-mitotic cells since some conflicting observations were made on the 
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nuclear envelope invaginations between C9-ALS iPSNs and postmortem cortical tissue from 
C9ORF72-associated ALS patients [211]. 
Genetic mutations in nuclear lamin genes cause a group of rare genetic disorders, collectively 
called laminopathies [212]. For instance, premature aging in Hutchinson-Gilford progeria syndrome 
(HGPS), caused by a lamin A/C mutation, manifests as cytological defects in the nuclear envelope and 
heterochromatin formation [213-215]. Lamin A/C mutations, including the pathogenic allele observed 
in HGPS, lead to disruption of the RAN gradient and NCT [216-219]. These mutant phenotypes appear 
to be mediated by loss of heterochromatin since genetic or pharmacological inhibition of 
heterochromatin formation by histone methyltransferases is sufficient to disrupt the RAN gradient and 
NCT [220]. Given our observation that poly(GR)-induced loss of nuclear integrity is rescued by RAN 
overexpression, these findings indicate possible interdependence among nuclear envelop integrity, 
heterochromatin formation, and the RAN gradient. Interestingly, loss of heterochromatin formation and 
nuclear lamina invaginations have been implicated in ALS/FTD-related pathogenic processes in a 
mouse model [221]. An additional layer of homology is likely present between HGPS and ALS/FTD, 
given that deficits in the nuclear import of DNA-repairing factors (e.g., ataxia-telangiectasia mutated 
kinase) may explain their common pathogenesis, which involves DNA damage-induced cell death [191, 
220, 222-224]. 
The nuclear pore complex is exceptionally long-lived in post-mitotic cells [112, 225], and its 
relevant function, such as NCT and nuclear integrity, declines with aging [215, 226, 227]. Emerging 
evidence indicates that cellular pathogeneses underlying distinct neurodegenerative diseases, including 
ALS/FTD, Alzheimer’s disease, and Huntington’s disease, may converge on the disruption of NCT 
[113-117]. Given our findings that EPAC1 acts as a gatekeeper in the vicinity of nuclear pores to 
facilitate RAN recycling and sustain robust NCT, the post-transcriptional circuit of LSM12-EPAC1 










RBPs are robustly expressed in central nervous system (CNS) with diverse cellular functions for axonal 
growth, arborization, differentiation, and synaptic plasticity [228-231]. Deficits in RBPs and subsequent 
disruption of gene expression are implicated in cognitive disorders, circadian dysfunction, and 
neurodegenerative diseases [46, 232, 233]. It is not surprising, therefore, that sophisticated regulatory 
function of RBPs are crucial for temporal dynamics in neural activity. As neurons are post-mitotic and 
highly polarized cells in our body, post-transcriptional regulation is thus emerging as key determinants 
that support qualitive and quantitative gene expression important for neural physiology [234].  
 ATXN2 represents RBPs that are responsible for the post-transcriptional control of specific 
RNA substrates and SG formation [46, 155]. We discover that ATXN2 protein complex switches 
between activator and repressor modes of post-transcriptional regulation via its associating factors 
LSM12 and ME31B/DDX6. It defines PERIOD-dependent and -independent clock functions of ATXN2 
that contribute to 24-hour periodicity and high-amplitude rhythms, respectively, in circadian behaviors 
in Drosophila. Furthermore, we demonstrate an unexpected role of LSM12 and its downstream effector, 
EPAC1 in establishing a robust nucleocytoplasmic gradient of RAN-GTP. Consequently, a post-
transcriptional circuit of LSM12-EPAC1 constitutes an ATXN2-independent neuroprotective pathway 
that sustains nucleocytoplasmic transport and suppresses neurodegenerative pathologies in C9-
ALS/FTD.  
Taken together, my thesis research provides a key understanding that LSM12 may have 
evolved physiology-specific regulatory mechanisms at post-transcriptional levels to support complex 
and prompt changes in neuronal gene expression and the relevant physiologies. Although we identified 
LSM12V135I as an ALS risk variant, it remains an open question how and in which mechanisms the 
LSM12 variant functions dominant-negative and neomorphic effects on the RAN gradient and NCT, 
respectively. Functional definition of key targets of LSM12 at either posttranscriptional (i.e., RNA 
substrates) or posttranslational levels (i.e., protein complex, RNA-RBP granules) will further elucidate 
how LSM12 contributes to neural homeostasis in a broader context, and how its dysfunction could 
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2014 년에 실험실 인턴십을 시작하였으니 벌써 7 년이라는 시간이 지났습니다. 어찌 
보면 아주 짧은 시간이지만, 돌이켜 생각해보면 힘들고도 긴 시간이었습니다. 많은 
분들의 도움과 지원, 그리고 가르침이 없었다면 학위 과정의 긴 터널을 지날 수 없었을 
것입니다. 제가 학부생 때부터 연구에 흥미를 가질 수 있도록 지도해주신 임정훈 
교수님께 제일 먼저 감사의 말씀 드립니다. 학생들을 동료 연구자로서 존중해주시고 늘 
학생의 입장에서 생각해 주신 지도 교수님 덕분에 학위과정을 무사히 마칠 수 
있었습니다. 그리고 연구에 흔쾌히 도움을 주신 UNIST 박태은 교수님, KAIST 윤기준 
교수님께 감사드립니다. 연구라는 것이 결코 혼자 할 수 있는 일이 아니며 서로 
협력하고 소통해야 앞으로 나아갈 수 있음을 배웠습니다. 또한 바쁘신 와중에도 
박사학위 논문심사를 맡아주신 UNIST 김홍태 교수님, 김재익 교수님, 고려대 김윤기 
교수님께 감사드립니다. 
LIMLAB 구성원들에게도 감사한 마음을 전합니다. 먼저 저의 생각과 의견에 귀 
기울여 주시고 학생의 입장에서 조언해 주신 이종빈 박사님께 감사드립니다. 그리고 
얼굴 표정만으로도 저의 기분을 이해해 주고 응원 해주신 화정 누나에게도 감사의 
말씀을 드립니다. 누나의 자상한 조언과 응원 덕분에 학위 과정을 무사히 마무리 할 수 
있었습니다. 제가 고민이 있거나 어려움에 처할 때마다 적극적으로 도움을 주신 지형 
형께도 감사합니다. 그리고 최고의 동료이자 든든한 조력자가 되어 주는 소울메이트 
은석이에게 고마움을 표합니다. 실험 결과와 가설을 항상 냉정하게 비판해준 
민종이에게도 고맙다는 말을 전합니다. 제가 실험실에 처음 들어왔을 때 실험실 생활에 
적응할 수 있도록 도움을 준 호연이, 부족한 선배임에도 잘 따라준 주민이, 희주, 현우 
에게도 고맙다는 말을 전합니다. 학위과정동안 동고동락한 동근, 종민, 영임, 지원, 성언, 
Terezia, 가을, 희진. 병은, 현진, 문성, 박근희 선생님과 추억을 함께할 수 있어서 
즐거웠습니다. 그리고 김용한 박사님, 두국, 우석, 진엽, 현규를 포함한 방송부 
식구들에게도 감사의 말씀을 전합니다. 3년이 넘는 시간 동안 함께 동고동락한 룸메이트 
창후 형께도 감사드립니다. 
마지막으로 제가 힘들고 지칠 때 변함없는 사랑으로 응원해 준 저희 가족들, 이모부, 
이모, 여자친구 은석이에게 고맙고 사랑한다는 말을 전합니다. 그리고 같은 길을 걷는 
든든한 선배이자 동료인 민우 형, 은진 누나 부부를 포함하여 항상 가족처럼 따뜻하게 
맞이해주시는 여자친구 가족들에게도 진심을 다해 감사의 마음을 전합니다.  
‘인간은 노력하는 한 방황한다’는 괴테의 명언처럼, 우리의 방황은 결국 가슴속에 
지향하며 바라는 바가 있기에 그러하다고 생각합니다. 따뜻하고 진실된 조언으로 저의 
방황을 아름답게 지켜주신 모든 분들께 다시 한번 감사의 말씀을 드립니다. 비굴하지 
않고 당당하며, 교만하지 않고 겸손한 모습으로 세상에 선한 영향력을 끼치는 사람이 
되겠습니다. 
 
